<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">J Proteomics Bioinform</journal-id>
			<journal-id journal-id-type="publisher-id">opg</journal-id>						
			<journal-title>Journal of Proteomics &amp; Bioinformatics</journal-title>			 
			<issn pub-type="epub">0974-276X</issn>
			<publisher>
				<publisher-name>OMICS Publishing Group</publisher-name>
				<publisher-loc>India, USA</publisher-loc>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">000063</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="Discipline">
					<subject>Biochemistry</subject>
				</subj-group>
				<subj-group subj-group-type="System Taxonomy">
					<subject>Proteomics</subject>
					<subject>Bioinformatics</subject>
					<subject>Genomics</subject>
					<subject>Transcriptomics</subject>
					<subject>Biomarkers</subject>
				</subj-group>
			</article-categories>
			<title-group> 
				<article-title>Homology Modeling and Functional Analysis of LPG2 Protein of <italic>Leishmania</italic> Strains</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Sahoo</surname>
						<given-names>Ganesh Chandra</given-names>
					</name>	
					<xref ref-type="aff" rid="a1">1</xref>					
				</contrib>	
				<contrib contrib-type="author">
					<name>
						<surname>Dikhit</surname>
						<given-names>Manas Ranjan</given-names>
					</name>	
					<xref ref-type="aff" rid="a1">1</xref>									
				</contrib>	
				<contrib contrib-type="author">
					<name>
						<surname>Rani</surname>
						<given-names>Mukta</given-names>
					</name>	
					<xref ref-type="aff" rid="a1">1</xref>					
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Das</surname>
						<given-names>Pradeep</given-names>
					</name>	
					<xref ref-type="aff" rid="a1">1</xref>					
				</contrib>						
			</contrib-group>
			<aff id="a1"><label>1</label>Rajendra Memorial Research Institute of Medical Sciences, Agam Kuan, Patna, India- 80007</aff>			
			<author-notes>
				<corresp id="cor1">&ast; To whom correspondence should be addressed: Ganesh Chandra Sahoo, Rajendra Memorial Research Institute of Medical Sciences Patna, Bihar INDIA; E-mail: <email>ganeshiitkgp@gmail.com</email></corresp>
			</author-notes>
			<pub-date pub-type="collection">
			     <month>01</month>
				 <year>2009</year>
			</pub-date>
			<pub-date pub-type="epub">
				<day>10</day>
				<month>01</month>
				<year>2009</year>
			</pub-date>			
			<volume>2</volume>
			<issue>1</issue>
			<fpage>032</fpage>
			<lpage>050</lpage>
			<history>
			<date date-type="received">
			     <day>27</day>
				 <month>11</month>
				 <year>2008</year>
			</date>
			<date date-type="accepted">
			      <day>06</day>
				  <month>01</month>
				  <year>2009</year>
			</date>
			</history>
			<permissions>
			<copyright-statement><bold>Copyright:</bold> &copy; 2009 Ganesh CS, et al.</copyright-statement>
			<copyright-year>2009</copyright-year>
			<license license-type="open access">
			<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
			</license>
			</permissions>			
			<abstract>
				<p>As drug resistance problem persists in case of Leishmaniasis, modeling and analysis of different essential proteins of <italic>Leishmania</italic> strains will help us further to discover novel lead compounds. Lipophosphoglycan 2 (LPG2) protein is required for the development of <italic>Leishmania</italic> throughout their life cycle, including for virulence to the mammalian host. LPG2 participates in a specialized virulence pathway, which may offer an attractive target for chemotherapy. Homology models of LPG2 of five <italic>Leishmania</italic> species have been constructed using the X-ray structures of different transporter proteins as templates, by comparative protein modeling principles. The resulting model has the correct stereochemistry as gauged from the Ramachandran plot and good three-dimensional (3-D) structure compatibility as assessed by the Procheck and <italic>Profiles-3D</italic> scores. Functional assignment of LPG2 protein of <italic>Leishmania</italic> strains by SVM revealed that along with transporters activity it also performs several novel functions e.g. iron-binding, sodium-binding, copper binding. It also belongs to protein of major facilitator family (MFS) and type II (general) secretory pathway (IISP) family. Important functional motifs have been identified in LPG2 protein of different <italic>Leishmania</italic> strains using different programs. Potential Ligand Binding Sites (LBSs) in LPG2 protein of these strains have been identified using Pocket Finder program. On the
basis of structure of ligand binding sites, particular LPG2 inhibitors can be designed. The similarity in the molecular structure, function and differences in LBSs of LPG2 of <italic>L. donovani, L. major, L. infantum, L. braziliensis </italic>and <italic>L. mexicana</italic> provide evidences for selective and specific LPG2 inhibitors.</p>
			</abstract>	
			<kwd-group>
				<kwd>LPG2 protein</kwd>
				<kwd>Leishmaniasis</kwd>
				<kwd>comparative (homology) modeling</kwd>
				<kwd>Phyre (Protein Homology/analogY Recognition Engine)</kwd>
				<kwd>SVM (Support Vector Machine)</kwd>		
				<kwd>Ligand Binding Sites (LBSs)</kwd>	
			</kwd-group>		
			<custom-meta-wrap>
				<custom-meta>
					<meta-name>citation</meta-name>
					<meta-value>Ganesh CS, Manas RD, Mukta R, Pradeep D (2009) Homology Modeling and Functional Analysis of LPG2
Protein of <italic>Leishmania</italic> Strains</meta-value>
				</custom-meta>
			</custom-meta-wrap>
		</article-meta>
	</front>
	<body>
	<sec>
		<title>Background</title>
			<p><italic>Leishmaniasis</italic> is identified by clinical syndromes caused by obligate intracellular protozoa of the genus <italic>Leishmania</italic> and transmitted from one host to another by the bite of blood sucking sand fly vectors. Visceral leishmaniasis also known as Kala-Azar (KA) is caused by <italic>Leishmania donovani</italic> and is fatal if it remains untreated (<xref ref-type="bibr" rid="r6">Bhattacharyya et al., 2002</xref>). It is typically a vector-borne zoonosis, with rodents as common reservoir hosts and humans as secondary hosts. Visceral leishmaniasis (VL), the most severe form (which is usually fatal if patients are untreated), which is due to <italic>Leishmania donovani</italic>, is common in less developed countries (<xref ref-type="bibr" rid="r32">Paris et al., 2004</xref>).<italic> Leishmania</italic> is endemic in large parts of the world with 600,000 new clinical cases reported annually and possibly more unreported (<xref ref-type="bibr" rid="r48">Vergnes et al., 2007</xref>).</p>
			<p>A short list of drugs includes SAG (Sodium Antimony Gluconate), amphotericin-B, pentamidine, and the oral drug miltefosine, which is in phase IV clinical trial in India (Bihar, Patna). Already a decrease in efficacy has been noted against this novel molecule (<xref ref-type="bibr" rid="r11">Croft et al., 2006</xref>). A comparative analysis of a genetically related pair of Sb (V)-sensitive and -resistant <italic>Leishmania donovani</italic> strains isolated from kala-azar patients revealed that the resistant isolate exhibited cross-resistance to other unrelated <italic>Leishmania</italic> drugs including miltefosine and amphotericin-B (<xref ref-type="bibr" rid="r48">Vergnes et al., 2007</xref>).</p> 
<p>Lipophosphoglycan (LPG) is the major cell surface molecule of promastigotes of all <italic>Leishmania</italic> species. It is comprised of three domains i.e. a conserved GPI anchor linked to a repeating phosphorylated disaccharide (P2; PO4-6-Gal (&beta;1-4) Man (&alpha;1- ) backbone variously substituted with galactose, glucose and arabinose residues in <italic>L. major</italic> and capped with a neutral oligosaccharide (<xref ref-type="bibr" rid="r30">Ng et al., 1994</xref>). The main surface glycoconjugate on promastigotes, lipophosphoglycan (LPG), is crucial for parasite survival (<xref ref-type="bibr" rid="r51">Winberg et al., 2007</xref>). </p>
<p>LPG2 encodes a 37 KDa protein of 341 amino acids, containing up to 10 transmembrane domains (<xref ref-type="bibr" rid="r12">Descoteaux et al., 1995</xref>; <xref ref-type="bibr" rid="r26">Ma et al., 2004</xref>). LPG2 is a member of a growing family of genes implicated in nucleotide-sugar transport. The family is large, covers several nucleotide-sugar specificities and is evolutionarily diverse including <italic>Leishmania</italic>, yeast, <italic>C. elegans</italic>, plants and humans (Ma et al., 2004). Because of its hydrophobicity, subcellular location, and similarity to other proteins implicated in transmembrane transport, LPG2 protein is golgi GDP-mannose transporter required for addition of disaccharide-phosphate units on lipophosphoglycan and related glycoconjugates (<xref ref-type="bibr" rid="r12">Descoteaux et al., 1995</xref>; Ma et al., 2004). The amino acid sequence of SQV-7 protein of <italic>C. elegans</italic> and <italic>Leishmania donovani</italic> protein, LPG2 are similar to each other (67 (20%) are identical), which is required for transport of GDP-mannose across membranes (<xref ref-type="bibr" rid="r12">Descoteaux et al., 1995</xref>; <xref ref-type="bibr" rid="r26">Ma et al., 2004</xref>). Such transporters are required to bring nucleotide sugars from the cytosol, where they are synthesized, into the endoplasmic reticulum and Golgi apparatus, where they are used as sugar-donor substrates by glycosyltransferases (<xref ref-type="bibr" rid="r1">Abeijon et al., 1997</xref>). The hydropathy plots of SQV-7 and LPG2 are highly similar (<xref ref-type="bibr" rid="r23">Kyte et al., 1982</xref>). Human cells have no detectable GDPmannose transport activity, yet there are at least two human proteins similar to LPG2; thus, it is likely that LPG2, SQV-7, and the two human proteins are members of a family of transporters that have a variety of nucleotide-sugar specificities (<xref ref-type="bibr" rid="r26">Ma et al., 2004</xref>).</p>
<p>For virulence and transmission, the protozoan parasite <italic>Leishmania</italic> assembles a complex glycolipid on the cell surface, the lipophosphoglycan (LPG). Functional complementation identified the gene LPG2, which encodes an integral golgi membrane protein implicated in intracellular compartmentalization of LPG biosynthesis. Ipg2- mutants lack only characteristic disaccharide-phosphate repeats, normally present on both LPG and other surface or secreted molecules considered critical for infectivity. In contrast, a related yeast gene, VAN2/VRG4, is essential and required for general golgi function. These results suggest that LPG2 participates in a specialized virulence pathway, which may offer an attractive target for chemotherapy (<xref ref-type="bibr" rid="r12">Descoteaux et al., 1995</xref>).</p>
<p>Epitope tagging experiments localized the LPG2 protein to the parasite&rsquo;s golgi apparatus, with the C-terminus located on the lumenal side (<xref ref-type="bibr" rid="r12">Descoteaux et al., 1995</xref>). Transient transfection of LPG2 expression constructs, suggested that LPG2 acts autonomously as the GDP-Man transporter. It is reported that LPG2 occurs in a hexameric complex in <italic>Leishmania</italic> and also showed that GDP-Man, GDP-Ara, and GDP-Fuc can be transported by this NST. These findings have important implications to the structure and function of the NST family in both <italic>Leishmania</italic> and other eukaryotes (<xref ref-type="bibr" rid="r20">Hong et al., 2000</xref>).</p>
<p>Entry of <italic>Leishmania</italic> into visceral organs can cause damage to visceral organs and neurodegenerative symptoms are likely to occur. Hence there is requirement of study on structural and functional characteristics of different proteins of <italic>Leishmania</italic> strains to target the protein to find a suitable anti-leishmanial drug. X-ray crystallographic structure is not available for this important protein of <italic>Leishmania</italic> species. Modeling of the LPG2 protein, assigning function to this protein, identifying different ligand binding sites will give us useful information regarding LPG2 protein.</p>
	</sec>
	<sec sec-type="methods">
		<title>Methodology</title>
			<sec>
				<title>Structural Modeling</title>
					<p>The sequence of LPG2 protein (341 amino acids) of <italic>Leishmania donovani</italic> was downloaded for structural modeling from NCBI. Multiple alignments of the related sequences were performed using the online available ClustalW
program accessible through the European Bioinformatics Institute (<xref ref-type="bibr" rid="r45">Thompson et al., 1994</xref>; http://www.ebi.ac.uk/Tools/ clustalw2/index.html). No X-ray crystallographic or NMR structure of this protein of any <italic>Leishmania</italic> species has yet been determined. Tertiary structures of LPG2 protein of different <italic>Leishmania</italic> strains were modeled on the basis of different template structures from PHYRE, I-Tasser. Structure validation was performed using ANOLEA, Profiles-3D, WHATIF, and Model-3D, molecular modeling tool (Profiles- 3D) of discovery studio.</p>
			</sec>
			<sec>
				<title>Transmembrane Region Prediction</title>
					<p>Different servers i.e. TMHMM, SOSUI, HMMTOP and TMpred servers were accessed to validate the TM region of LPG2 protein (<xref ref-type="bibr" rid="r21">Krogh et al., 2001</xref>; <xref ref-type="bibr" rid="r18">Hirokawa et al., 1998</xref>, <xref ref-type="bibr" rid="r46">Tusna&Acirc;dy et al., 1998</xref>; <xref ref-type="bibr" rid="r19">Hofmann et al., 1993</xref>). TMHMM, a new membrane protein topology prediction method, is based on a hidden Markov model.</p>
			</sec>
			<sec>
				<title>Ligand Binding Site Prediction</title>
					<p>Pocket-Finder is a pocket detection algorithm based on Ligsite written by <xref ref-type="bibr" rid="r17">Hendlich et al (1997)</xref>. Pocket-Finder works by scanning a probe radius 1.6A&deg; along all gridlines of grid resolution 0.9 A&deg; surrounding the protein. The probe also scans cubic diagonals. Grid points are defined to be part of a site when the probe is within range of protein atoms followed by free space followed by protein atoms. Grid points are only retained if they are defined to be part of a site at least five times (<xref ref-type="bibr" rid="r17">Hendlich et al., 1997</xref>).</p> 
			</sec>
			<sec>
				<title>Protein Function Assignment of LPG2 Protein by SVM</title>
					<p>To know novel functions of LPG2 protein of different <italic>Leishmania</italic> strains were searched at BIDD (<xref ref-type="bibr" rid="r9">Cai et al., 2003</xref>; http://jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi). The web-based software, SVMProt, support vector machine(SVM) classifies a protein into functional families from its primary sequence based on physico-chemical properties of amino acids (<xref ref-type="bibr" rid="r9">Cai et al., 2003</xref>). Novel protein function assignment of different proteins of SARS virus and <italic>Japanese encephalitis</italic> virus has already been reported (<xref ref-type="bibr" rid="r8">Cai et al., 2005</xref>; <xref ref-type="bibr" rid="r39">Sahoo et al., 2008</xref>).</p>
			</sec>
			<sec>
				<title>ELM (Eukaryotic Linear Motif) Server</title>
					<p>Functional sites in eukaryotic proteins which fit to the description &ldquo;linear motif&rdquo; are currently specified as patterns using regular expression rules. ELM server provides core functionality including filtering by cell compartment, phylogeny, globular domain clash (using the SMART/ Pfam databases) and structure (<xref ref-type="bibr" rid="r34">Puntervoll et al., 2003</xref>). Individual functions assigned to different sequence segments combine to create a complex function for the whole protein.</p>
			</sec>
			<sec>
				<title>PredictProtein Server</title>
					<p>Predict Protein provides PROSITE sequence motifs, lowcomplexity regions (SEG), nuclear localization signals, regions lacking regular structure (NORS) and predictions of secondary structure, solvent accessibility, globular regions,
transmembrane helices, coiled-coil regions, structural switch regions, disulfide-bonds, sub-cellular localization, and functional 
annotations (<xref ref-type="bibr" rid="r34">Puntervoll et al., 2003</xref>; <xref ref-type="bibr" rid="r37">Rost et al., 2004</xref>; <xref ref-type="bibr" rid="r4">Bairoch et al., 1997</xref>; <xref ref-type="bibr" rid="r10">Ceroni et al., 2004</xref>).</p>
				<fig id="g1">
					<label>Figure 1</label>
					<caption>
						<title>Involvement of different amino acids in formation of nine trans-membrane regions of LPG2 protein of different <italic>Leishmania</italic> strains.</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g001.tif"/>
				</fig>
			</sec>
	</sec>		
	<sec>
		<title>Result and Discussion</title>
			<p>Structure, function and ligand binding site analysis of LPG2 protein will lead to identification of novel targets for design of suitable lead compounds inhibiting the specific functions of <italic>L. donovani, L. major</italic> and <italic>L. infantum</italic>.</p>
			<sec>
				<title>Transmembrane Region Prediction</title>
					<p>Different servers have been accessed for accurate prediction analysis of transmembrane region e.g. TMHMM,
HMMTOP, SOSUI and TMpred. Trans-membrane prediction analysis found that LPG2 protein of <italic>L. infantum</italic> and <italic>L. donovani</italic> are having same number of transmembrane regions (ten) and involvement of particular amino acids in the
TM regions is similar. The LPG2 sequences of <italic>L. infantum</italic> and <italic>L. donovani</italic> are very similar to each other except at two positions 220 and 221 where threonine (T) is replaced by isoleucine (I) and methionine (M) respectively in <italic>L. infantum</italic>. Even if the number of transmembrane region are same (ten) in <italic>L. mexicana, L. donovani</italic> and <italic>L. infanum</italic>, it is found that 3<sup>rd</sup> and 4<sup>th</sup> transmembrane regions are different
(3<sup>rd</sup> TM region comprises of aa 72-94 and 4<sup>th</sup> TM comprises 98-120 amino acids) in <italic>L. mexicana</italic> whereas in <italic>L. infantum</italic> and <italic>L. donovani</italic> it is coded by 77-99 and 101- 123 amino acids. LPG2 of <italic>L. braziliensis</italic> and <italic>L. major</italic> both comprise of nine TM regions but the transmembrane regions are quite different, only in few cases these are similar. Involvement of different amino acids in formation of nine different trans-membrane regions of different <italic>Leishmania</italic> strains is shown in (<xref ref-type="fig" rid="g1">Figure.1</xref>).</p>
<p>Multiple alignment of amino acid sequences of LPG2 protein of different <italic>Leishmania</italic> strains shows that they are
very close to each other ranging from 78-99% (<xref ref-type="table" rid="t1">Table 1</xref>). Multiple alignment of LPG2 protein shows that <italic>Ldv</italic> and <italic>L.infantum</italic> are having 99% identity (<xref ref-type="fig" rid="g2">Figure. 2</xref>). From phylogram, LPG2 protein of <italic>L. braziliensis</italic> is found to be far from other <italic>Leishmania</italic> strains (<xref ref-type="fig" rid="g3">Figure.3</xref>). Many amino acid changes are found to be present towards the carboxy terminus in the annotated amino acid sequences.</p>
			</sec>
			<sec>
				<title>Structure Analysis of LPG2 Protein</title>
					<p>Five different models of LPG2 protein of different <italic>Leishmania</italic>strains were screened for profiles-3d score of DS(Accelrys). The best model of different <italic>Leishmania</italic> strains were screened by profiles-3d score and the best was selected for further analysis. About 14 - 27 helices have been predicted for LPG2 protein of different models of various <italic>Leishmania</italic> strains. The best model of LPG2 protein of <italic>L. infantum</italic> contains 22 helices, whereas 19 helices are there in case of <italic>L. donovani</italic> and <italic>L. major</italic>. The models for LPG2 protein of different <italic>Leishmania</italic> strains are shown in <xref ref-type="fig" rid="g4">Figure 4.</xref> The profiles-3D scores of best predicted models of LPG2 protein of various <italic>Leishmania</italic> strains (<xref ref-type="table" rid="t2">Table 2</xref>), shows that highest score (111.29) has been found in case of LPG2 protein model of <italic>L. major</italic> and lowest score (91.23) has been found in case of <italic>L. braziliensis</italic>. Invalid regions have been detected in different models. Highest numbers of invalid regions have been found in one model of <italic>L. mexicana</italic> whereas lowest number of invalid regions is found in other models of <italic>L. mexicana, L. major</italic> and <italic>L. donovani</italic>. On further side chain and loop modeling refinements of the predicted models of LPG2 protein, the profiles-3D score is found to be decreased. In Ramachandran plots (Procheck), 88- 91% residues belong to core region, 6-8 % residue in allowed region, 1-2.5% in generously allowed regions and 1- 3% in disallowed regions (<xref ref-type="table" rid="t3">Table 3</xref>). From Ramachandran plot, it is known that maximum residues in LPG2 protein are responsible for formation of helices. Also transmembrane region prediction analysis detected nine or ten transmembrane regions to be present in LPG2 protein of all these strains. Hence there is involvement of helices in formation of LPG2 protein.</p>
			<fig id="g2">
					<label>Figure 2</label>
					<caption>
						<title>Multiple alignment of amino acid sequences of LPG2 protein of different <italic>Leishmania</italic> strains.</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g002.tif"/>
				</fig>
				<fig id="g3">
					<label>Figure 3</label>
					<caption>
						<title>Phylogram showing phylogenetic relationship of LPG2 protein of different <italic>Leishmania</italic> strains (<italic>L. donovani, L. major, L. infantum, L. mexicana</italic> and <italic>L. braziliensis</italic>).</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g003.tif"/>
				</fig>
				<fig id="g4">
					<label>Figure 4</label>
					<caption>
						<title>Ribbon representations of the modeled LPG2 protein images of all different <italic>Leishmania</italic> strains using Discovery Studio 2.0 (Accelrys) software (a)<italic> L. donovani</italic>, (b) <italic>L. major</italic>, (c) <italic>L. infantum</italic> (d) <italic>L. mexicana</italic> and (e) <italic>L. braziliensis</italic>.</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g004.tif"/>
				</fig>
<p>The models of different Leishmania strains were based on template PDB coordinates of 2i68, 1ee4, 1pw4, 1ej1, 3b5d and 1xm9. The PDB &lsquo;2i68&rsquo; codes for transmembrane domain of the multi drug resistance antiporter from E. coli Emr E. This protein has antiporter activity and belongs to a family of plasma membrane proteins and proteins integral to membrane. The PDB &lsquo;1pw4&rsquo; codes for protein with transporter activity and belongs to MFS general substrate transporter fold and is involved in glycerol metabolic process and glycerol 3-phosphate transport. It is a protein of plasma membrane and protein integral to membrane. The PDB &lsquo;1xm9&rsquo; codes for structure of armadillo repeat domain of plakophilin 1, belongs to all alpha proteins with alpha alpha superhelix fold which has ARM repeat forming plakophilin 1 domain . This protein is involved in molecular functions like signal transduction, cell adhesion and protein binding. The PDB &lsquo;3b5d&rsquo; codes for x-ray crystallographic structure of Emr E multidrug transporter in complex with TPP, involved in antiporter like transporter function. It is a plasma membrane component. Few drugs have been targeted to this protein like dapsone and tamoxifen. The PDB coordinates of &lsquo;1ee4&rsquo; code for crystal structure of yeast karyopherin (importin) in a complex with a c-myc NLS peptide. This karyophilin alpha protein have armadillo domain with ARM repeat. This protein is classified as transporter protein which is a transmembrane protein with transporter activity involved in import into nucleus, protein targeting to membrane and intracellular transport. This is a leucine rich alpha helical protein. The PDB coordinates of &lsquo;1ej1&rsquo; code for crystal structure of mRNA 5&rsquo;cap binding protein (eIF 4E) bound to 7-methyl-GDP. This protein is having RNA binding and translation factor activity and belongs to class of alpha and beta proteins. From all these template analyses, it is found that except &lsquo;1ej1&rsquo;, all other templates are transporter&ndash;like protein. LPG2 protein also belongs to this group of protein.</p>
<p>It is found that the best model of LPG2 protein of all these strains consisted of only one chain (<xref ref-type="table" rid="t2">Table 2</xref>). In all the models 68-73 percent is helical. The best model of LPG2 protein of <italic>L. donovani</italic> is having highest number (24) of helices where minimum five and maximum sixteen residues take part in formation of a helix. In <italic>L. donovani</italic> three 3<sub>10</sub> helices are present. In <italic>L. mexicana</italic> 28 residues has been found to be forming a helix and helices in this strain accounts for 73% of total residues.</p>
			</sec>
			<sec>
				<title>Functional Assignment of LPG2 Protein by SVM</title>
					<p>From the comparative analysis of LPG2 protein functional assignment of five <italic>Leishmania</italic> strains shows that it belongs to transporter group of proteins (<xref ref-type="table" rid="t4">Table 4</xref>). LPG2 protein also belonged to trans-membrane region protein. LPG2 protein of <italic>L. mexicana</italic> strain M379 belonging to copper binding (58.6%), magnesium binding (58.6%), metal-binding, iron-binding (73.8%) and sodium-binding (78.4 %) protein function families. It also belongs to type II (general) secretory pathway (IISP) family and major facilitator family (MFS) (58.6%). LPG2 protein of <italic>L. braziliensis</italic> also belongs to incompletely characterized transport systems - putative uncharacterized transport proteins (73.8%), G protein coupled receptors (58.6%) and major facilitator family (MFS) (58.6%). From NCBI, it is also known that this protein is a nucleotide sugar transporter protein which is also likely to be post-translationally modified and belongs to chaperone or intracellular trafficking group of proteins.</p>
<p>Various post-translational modification sites for LPG2 protein of various <italic>Leishmania</italic> strains were identified using protein predict program. Two aspargine glycosylation sites (at 2<sup>nd</sup> amino acid [NHTR] and at 335<sup>th</sup> amino acid [NDTS]) have been found in <italic>L. infantum</italic> and <italic>L. donovani</italic> whereas only one glycosylation site at 2<sup>nd</sup> amino acid [NHTR] was found in other three <italic>Leishmania</italic> strains (<xref ref-type="table" rid="t5">Table 5</xref>). Two protein kinase C activation sites were predicted in three <italic>Leishmania</italic> strains and one PKC site was predicted in other two strains. Four casein kinase II phosphorylation (CKP) sites are present in two <italic>Leishmania</italic> strains whereas in other strains one or two CKPs are present. One to five numbers of N-myristoylation sites are present in different <italic>Leishmania</italic> strains. Only one disulfide bond between 20<sup>th</sup> and 244<sup>th</sup> amino acid residues was detected in this protein of different <italic>Leishmania</italic> strains (<xref ref-type="table" rid="t5">Table 5</xref>).</p>
<p>ELM server detected short functional sites in LPG2 protein. In <italic>L donovani, L. major</italic> and <italic>L. infantum</italic>, phosphothreonine motif binding a subset of FHA domains having a preference for an acidic amino acid at the pT+3 position (Nucleus, Replication fork) (LIG_FHA_2) has been predicted at 318-324[GKTTAES] position. In <italic>L. braziliensis</italic>
the predicted site and amino acids involved were different (Site 306-312 and sequence is SATDAEN) (<xref ref-type="table" rid="t6">Table 6</xref>). Since phosphorthreonine motif of LPG2 protein of <italic>L. braziliensis</italic> is different, according to this motif, LPG2 protein of all other four <italic>Leishmania</italic> strains are homologous to each other which is also confirmed by Clustal W and phylogenetic analysis. From analogy point of view, all the five strains are equal as the phosphothreonine motif is found in all five <italic>Leishmania</italic> strains.</p>
<p>The MAP kinase (MAPK) cascades convey a signal in form of phosphorylation events. MAPKs are phosphorylated by MAP kinase kinases (MAPKKs), phosphorylate various targets, such as transcription factors and MAPKactivated protein kinases (MAPKAPKs), and are dephosphorylated and inactivated by several MAPK-phosphatases (MKPs) (<xref ref-type="bibr" rid="r43">Sturgill et al., 1991</xref>; <xref ref-type="bibr" rid="r2">Ahn et al., 1992</xref>; <xref ref-type="bibr" rid="r31">Nishida et al., 1993</xref>; <xref ref-type="bibr" rid="r27">Marshall et al., 1995</xref>). In LPG2 protein of three <italic>Leishmania</italic> strains, MAPK interacting molecules (e.g. MAPKKs, substrates, phosphatases) carrying docking motif helping to regulate specific interaction in the MAPK cascade, have been detected in 75- 82 residues (<xref ref-type="table" rid="t6">Table 6</xref>).</p>
<p>Amino acid sequence &ldquo;GRLVLA&rdquo; (223<sup>rd</sup> - 228<sup>th</sup>) of <italic>L. mexicana</italic>, was found to have an RXXL motif that binds to the Cdh1 and Cdc20 components of APC/C thereby targeting the protein for destruction in a cell cycle dependent manner (<xref ref-type="table" rid="t6">Table 6</xref>).</p>
<p>Cell cycle depends upon the well orchestrated activation and deactivation of cyclin-dependent kinases which phosphorylate a number of substrates required for entry into the next phase of the cell cycle (<xref ref-type="bibr" rid="r44">Takeda et al., 2001</xref>). Three substrate recognition sites have been identified in LPG2 protein of <italic>Leishmania</italic> strains that interact with cyclin and thereby increase phosphorylation by cyclin / cdk complexes which are required for cell cycle events. Predicted proteins also have the MOD_CDK sites which are used by cyclin inhibitors (<xref ref-type="table" rid="t6">Table 6</xref>).</p>
<p>USP7 plays an important role in regulating cell proliferation and apoptosis through p53 and Mdm2 interactions (<xref ref-type="bibr" rid="r40">Saridakis et al., 2005</xref>). Motif containing amino acid sequence[AKASS-304<sup>th</sup> -308<sup>th</sup>] of LPG2 protein of four <italic>Leishmania</italic> strains is the USP7 NTD domain binding motif variant based on the MDM2 and P53 interactions, this site is absent in <italic>Leishmania braziliensis</italic> (<xref ref-type="table" rid="t6">Table 6</xref>).</p> 
<p>WW domain is one of the domains mediating cellular processes which require physical interactions between proteins (<xref ref-type="bibr" rid="r5">Bedford et al., 1998</xref>). Two to four numbers of class IV WW domains interaction motifs (phosphorylation-dependent interaction motifs found in both nuclear and cytosolic proteins) are present in LPG2 protein of <italic>Leishmania</italic> strains (<xref ref-type="table" rid="t6">Table 6</xref>).</p>
<p>CK1 is a &lsquo;&lsquo;phosphate-directed&rsquo;&rsquo; protein kinase which is able to phosphorylate with high efficiency Ser/Thr residues specified by a prephosphorylated side chain (either pS or pT) at position n&ndash;3 (or less effectively n&ndash;4) (<xref ref-type="bibr" rid="r28">Meggio et al., 1979</xref>; <xref ref-type="bibr" rid="r13">Donella-Deana et al.,1985</xref>; <xref ref-type="bibr" rid="r15">Flotow et al., 1990</xref>). This observation led to the concept of &lsquo;&lsquo;hierarchical phosphorylation&rsquo;&rsquo; (<xref ref-type="bibr" rid="r36">Roach et al., 1991</xref>) and the term &lsquo;&lsquo;primed phosphorylation&rsquo;&rsquo; to indicate the ability to phosphorylate residue(s) specified by another phosphorylated residue at a predetermined (critical) position. This feature is shared by a small number of acidophilic Ser/Thr kinases, notably CK1 and CK2, glycogen synthase kinase 3 (GSK3), and the Golgi apparatus casein kinase (G-CK) (<xref ref-type="bibr" rid="r33">Pinna et al., 1996</xref>). Casein kinase I have a wide variety of substrates. CK1 phosphorylation motifs (7-11 numbers) (throughout the LPG2 sequence) have been identified in LPG2 protein of <italic>Leishmania</italic> strains. Reports on various CK1 inhibitors are known which can be applied to LPG2 protein by docking to find novel drug candidates for leishmanisis treatment (<xref ref-type="table" rid="t6">Table 6</xref>) (<xref ref-type="bibr" rid="r35">Rena et al., 2004</xref>). Protein kinase CK2 is a pleiotropic and ubiquitous serine or threonine kinase, which is highly conserved during evolution (<xref ref-type="bibr" rid="r14">Faust et al., 2000</xref>). Protein kinase CK2 can phosphorylate many protein substrates in addition to casein. CK2 phosphorylation motifs have been identified in LPG2 protein of <italic>Leishmania</italic> strains, one at the beginning of amino terminus and others towards carboxy terminus.</p>
<p>Glycogen synthase kinase 3 (GSK3) is a well conserved serine/threonine kinase that is implicated in different cellular processes controlling cell proliferation and programmed cell death (<xref ref-type="bibr" rid="r16">Frame et al., 2001</xref>). In resting cells, GSK3 is a constitutively active kinase that phosphorylates a wide range of protein substrates to directly inhibit their biochemical activities, interfere with their sub-cellular localization, or promote their degradation (<xref ref-type="bibr" rid="r3">Ali et al., 2001</xref>). GSK3 phosphorylation recognition sites are found in LPG2 protein throughout the sequence of <italic>Leishmania</italic>. On comparison of GSK3 sites, amino acids involved in formation of this recognition site are same but in few cases it is different.</p>
<p>N-glycosylation motifs have been detected in different strains at the beginning of N-terminal and towards carboxy terminus. In LPG2 protein of <italic>L. braziliensis</italic>, three Nglycosylation motifs are present. Among the different types of glycosylation, the N-linked attachment of sugars to the polypeptide backbone is by far the most abundant modification (<xref ref-type="bibr" rid="r49">Vijay et al., 1998</xref>).</p>
<p>Two proline-directed kinase (e.g. MAPK) phosphorylation sites (124-130 and 246-252) are found in four <italic>Leishmania</italic> strains whereas in <italic>L. braziliensis</italic>, four PDK phosphorylation sites are present. One way that they achieve
this is through direct interactions with substrate residues flanking the phosphorylation (P) site (<xref ref-type="bibr" rid="r33">Pinna et al., 1996</xref>; <xref ref-type="bibr" rid="r25">Lu et al., 2002</xref>; <xref ref-type="bibr" rid="r41">Songyang et al., 1996</xref>). The preference for proline at the P+1 position may be linked to downstream signaling mechanisms mediated by Pin1 proline isomerization (<xref ref-type="bibr" rid="r52">Zhou et al., 1999</xref>).</p>
<p>Tyrosine-based sorting signal sequences have been found throughout the LPG2 protein sequence of <italic>Leishmania</italic> which is responsible for the interaction with mu subunit of AP (adaptor protein) complex. Multiple sorting steps within eukaryotic
cells are mediated by tyrosine-based sorting motifs. These motifs are recognized by the medium-chain subunits of heterotetrameric adaptor complexes (<xref ref-type="bibr" rid="r42">Stephens et al., 1998</xref>).</p>
<p>Some proteins re-exported from the nucleus contain a leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein. CRM1 mediates the nuclear export of proteins exposing leucine-rich nuclear-export signals (NESs) (<xref ref-type="bibr" rid="r22">Kutay et al., 2005</xref>). Two such motifs [36<sup>th</sup> - 47<sup>th</sup> and 103<sup>rd</sup> -118<sup>th</sup> amino acids] are detected in LPG2 protein of <italic>Leishmania</italic> strains except <italic>L. major</italic> where only one site [36<sup>th</sup> - 47<sup>th</sup> amino acids] is present. Hence the LPG2 protein manufactured in nucleus is transported to cytosol or Golgi due to presence of these motifs in LPG2 protein itself.</p> 
<p>Interestingly, the sequences &ldquo;KTTTES&rdquo; and &ldquo;KAQTPS&rdquo; of LPG2 protein of <italic>L. major</italic> and <italic>L. infantum</italic> respectively matches a 14-3-3 interaction consensus site derived from natural interactors. Dimerization of 14-3-3 is essential for a good interaction (<xref ref-type="bibr" rid="r7">Cahill et al., 2001</xref>; <xref ref-type="bibr" rid="r47">Tzivion et al., 1998</xref>). P53 tumor suppressor protein, which plays a major role in maintaining genomic stability, has only one 14-3-3 binding site (<xref ref-type="bibr" rid="r50">Waterman et al., 1998</xref>). Hence LPG2 protein of <italic>Leishmania</italic> may have genomic stability role, which is required to be proved experimentally.</p>
<p>Only novel motif [FKSE] recognized for modification by SUMO-1 has been identified in LPG2 protein of <italic>L. major</italic>.
The small, ubiquitin-related protein SUMO-1 is highly conserved from yeast to humans (<xref ref-type="bibr" rid="r29">Muller et al., 2001</xref>) and has been associated with subnuclear localization of many cellular proteins. Like ubiquitination, sumoylation leads to attachment of SUMO-1 to target proteins through the &gamma;-NH2 group of lysine residues, using a cascade of E1, E2, and E3 enzymes. SUMO-1 is an important determinant of protein localization, required for the speckled nuclear distribution of the proteins PML, TEL, and HIPK2.</p>
<p>Likewise major TRAF2-binding consensus motif found in members of the tumor necrosis factor receptor (TNFR) superfamily, which initiate intracellular signaling by recruiting the C-domain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails, is also present in LPG2 protein of only one strain i.e. <italic>L. braziliensis</italic>.</p>
<p>In this analysis we have identified many motifs in LPG2 protein of <italic>Leishmania</italic>, which were previously reported in other proteins of different organisms, i.e. yeast to mammals. It is learned from this computational analysis that in LPG2 protein of <italic>L. braziliensis</italic> several distinct motifs are present which are not found in other <italic>Leishmania</italic> strains. The graphical view of all the motifs that present in LPG2 protein of all <italic>Leishmania</italic> Strains are shown in (<xref ref-type="fig" rid="g5">Figure. 5</xref>).</p>
			<fig id="g5">
					<label>Figure 5</label>
					<caption>
						<title>This graph shows involvement of different conserved motifs in LPG2 protein of different <italic>Leishmania</italic> strains from ELM Server. Different colors have been used to distinguish the presence of various motifs in different <italic>Leishmania</italic> strains.</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g005.tif"/>
				</fig>
			</sec>
			<sec>
				<title>Protein Ligand Binding Site Analysis</title>
					<p>Potential ligand binding sites in LPG2 protein of all <italic>Leishmania</italic> strains (<italic>L. donovvani, L. major, L. infantum, L. mexicana</italic> and <italic>L. braziliensis</italic>) have been found by using pocket finder program (<xref ref-type="table" rid="t7">Table 7</xref>) (<xref ref-type="bibr" rid="r38">Ruppert et al., 1997</xref>). Different LBSs of LPG2 protein of <italic>Leishmania</italic> are shown in (<xref ref-type="fig" rid="g6">Figure. 6</xref>). First LBS of all the strains involve more than 35 amino acids. At most thirty eight amino acids (<italic>L. mexicana</italic>) involved in formation of binding sites have been found and in few sites a single amino acid is changed or lacking in formation of ligand binding sites, have been detected. Lowest number (four) of amino acids involved in formation of LBSs has been found in <italic>L. infantum</italic> (7<sup>th</sup>). It is known from this analysis that some LBSs are similar in all the strains but other LBSs are specific to each strain. All LBSs of <italic>L. donovani</italic> and <italic>L. mexicana</italic> are very similar, except at 1<sup>st</sup> and 6<sup>th</sup> where one amino acid is absent in <italic>L. donovani</italic> (1<sup>st</sup> site: G-188<sup>th</sup> and 6<sup>th</sup> site: V-328<sup>th</sup>).</p>
					<fig id="g6">
					<label>Figure 6</label>
					<caption>
						<title>Prediction of Ligand Binding Sites (LBSs) of LPG2 protein of five Leishmania strains by the pocket finder program (a) L. donovani, (b) L. major, (c) L. infantum (d) L. mexicana and (e) L. braziliensis.</title>
					</caption>
					<graphic xlink:href="JPB-02-032-g006.tif"/>
				</fig>
<p>All these structural, functional and proteomic analysis about LPG2 protein of <italic>Leishmania</italic> species will lead to identification of novel lead compounds to eliminate <italic>Leishmania</italic> infection in Bihar state, India.</p>
			</sec>
	</sec>	
	<sec>
		<title>Future Perspectives</title>
			<p>As the structure of LPG2 protein is known from this study, novel lead compounds can be designed on the basis of ligand protein interaction (docking) scores of available antileishmanial drugs with LPG2 protein, defining the highest
dockable compound and designing various analogues of the presently available drugs or defining a novel molecule on the basis of different binding sites of LPG2 protein of different <italic>Leishmania</italic> strains.</p>
	</sec>				
	</body>
	<back>
	<ack>
			<p>This study was supported by Indian Council of Medical Research (ICMR), Govt. of India. We are thankful to Dr. Meera Singh of ICMR for helping us during establishment of our division. We acknowledge Dr. Sindhu Prava Rana for helping us in preparation of the manuscript.</p>
		</ack>
	<ref-list>
			<title>References</title>
				<ref id="r1">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Abeijon</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Mandon</surname>
							<given-names>EC</given-names>
						</name>	
						<name>
							<surname>Hirschberg</surname>
							<given-names>CB</given-names>
						</name>			
						</person-group>
						<year>1997</year>
						<article-title>Transporters of nucleotide sugars, nucleotide sulfate and ATP in the Golgi apparatus</article-title>
						<source>Trends Biochem Sci</source>
						<volume>22</volume>
						<fpage>203</fpage>
						<lpage>207</lpage>
			</citation>
			</ref>
			<ref id="r2">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ahn</surname>
							<given-names>NG</given-names>
						</name>
						<name>
							<surname>Seger</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Krebs</surname>
							<given-names>EG</given-names>
						</name>											
						</person-group>
						<year>1992</year>
						<article-title>The mitogen-activated protein kinase activator</article-title>
						<source>Curr Opin Cell Biol</source>
						<volume>4</volume>
						<fpage>PP992</fpage>
						<lpage>999</lpage>
			</citation>
			</ref>
			<ref id="r3">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ali</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Hoeflich</surname>
							<given-names>KP</given-names>
						</name>	
						<name>
							<surname>Woodgett</surname>
							<given-names>JR</given-names>
						</name>							
						</person-group>
						<year>2001</year>   
						<article-title>Glycogen synthase kinase-3: properties, functions, and regulation</article-title>
						<source>Chem Rev</source>
						<volume>101</volume>
						<fpage>2527</fpage>
						<lpage>2540</lpage>
			</citation>
			</ref>
			<ref id="r4">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Bairoch</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Bucher</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Hofmann</surname>
							<given-names>K</given-names>
						</name>									
						</person-group>
						<year>1997</year>
						<article-title>PROSITE: Nucleic Acids Research</article-title>					
						<volume>25</volume>
						<fpage>217</fpage>
						<lpage>221</lpage>
			</citation>
			</ref>
			<ref id="r5">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Bedford</surname>
							<given-names>MT</given-names>
						</name>
						<name>
							<surname>Reed</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Leder</surname>
							<given-names>P</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>WW domain-mediated interactions reveal a spliceosome-associated protein that binds a third class of proline-rich motif: The proline glycine and methionine-rich motif</article-title>
						<source>Proc Natl Acad Sci USA</source>
						<volume>95</volume>
						<fpage>10602</fpage>
						<lpage>10607</lpage>
			</citation>
			</ref>
			<ref id="r6">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Bhattacharyya</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Mukherjee</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Duttagupta</surname>
							<given-names>S</given-names>
						</name>
						</person-group>
						<year>2002</year> 
						<article-title>Studies on Stibanate unresponsive isolates of Leishmania donovani</article-title> 
						<source>J Biosci</source>
						<volume>27</volume>
						<fpage>503</fpage>	
						<lpage>508</lpage>					
			</citation>
			</ref>
			<ref id="r7">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Cahill</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>Tzivion</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Nasrin</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Ogg</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Dore</surname>
							<given-names>J</given-names>
						</name><etal/>
						</person-group>
						<year>2001</year>
						<article-title>Phosphatidylinositol 3-kinase signaling inhibits DAF-16 DNA binding and function via 14-3-3-dependent and 14-3-3-independent pathways</article-title>
						<source>J Biol Chem</source>
						<volume>276</volume>
						<fpage>13402</fpage>
						<lpage>13410</lpage>
			</citation>
			</ref>
			<ref id="r8">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Cai</surname>
							<given-names>CZ</given-names>
						</name>
						<name>
							<surname>Han</surname>
							<given-names>LY</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Cao</surname>
							<given-names>ZW</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>YZ</given-names>
						</name>		
						</person-group>
						<year>2005</year>
						<article-title>Prediction of Functional Class of the SARS Coronavirus Proteins by a Statistical Learning Method</article-title>
						<source>J Proteome Res</source>
						<volume>4</volume>
						<fpage>1855</fpage>
						<lpage>1862</lpage>
			</citation>
			</ref>
			<ref id="r9">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Cai</surname>
							<given-names>CZ</given-names>
						</name>
						<name>
							<surname>Han</surname>
							<given-names>LY</given-names>							
						</name>
						<name>
							<surname>Ji</surname>
							<given-names>ZL</given-names>							
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>X</given-names>							
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>YZ</given-names>							
						</name>
						</person-group>
						<year>2003</year>
						<article-title>SVMProt: Web-Based Support Vector Machine Software for Functional Classification of a Protein from Its Primary Sequence</article-title>
						<source>Nucleic Acids Res</source>
						<volume>31</volume>
						<fpage>3692</fpage>
						<lpage>3697</lpage>
			</citation>
			</ref>
			<ref id="r10">
					<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ceroni</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Frasconi</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Passerini</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Vullo</surname>
							<given-names>A</given-names>
						</name>				
						</person-group>
						<year>2004</year>
						<article-title>Disulfide connectivity prediction using recursive neural networks and evolutionary information</article-title>
						<source>Bioinformatics</source>
						<volume>20</volume>
						<fpage>653</fpage>
						<lpage>659</lpage>
			</citation>
			</ref>
			<ref id="r11">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Croft</surname>
							<given-names>SL</given-names>
						</name>
						<name>
							<surname>Sundar</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Fairlamb</surname>
							<given-names>AH</given-names>
						</name>
						</person-group>
						<year>2006</year>
						<article-title>Drug resistance in leishmaniasis</article-title>
						<source>Clinical Microbiol Rev</source>
						<volume>19</volume>
						<fpage>111</fpage>
						<lpage>126</lpage>
			</citation>
			</ref>
			<ref id="r12">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Descoteaux</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Luo</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Turco</surname>
							<given-names>SJ</given-names>
						</name>
						<name>
							<surname>Beverley</surname>
							<given-names>SM</given-names>
						</name>
						</person-group>
						<year>1995</year>
						<article-title>A specialized pathway affecting virulence glycoconjugates of Leishmania</article-title>
						<source>Science</source>
						<volume>269</volume>
						<fpage>1869</fpage>
						<lpage>1872</lpage>						
			</citation>
			</ref>
			<ref id="r13">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Donella</surname>
							<given-names>DA</given-names>
						</name>
						<name>
							<surname>Grankowski</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Kudlicki</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Szyszka</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Gasior</surname>
							<given-names>E</given-names>
						</name><etal/>
						</person-group>
						<year>1985</year>
						<article-title>A type-1 casein kinase from yeast phosphorylates both serine and threonine residues of casein. Identification of the phosphorylation sites</article-title>
						<source>Biochim Biophys Acta</source>
						<volume>829</volume>
						<fpage>180</fpage>
						<lpage>187</lpage>
				</citation>
			</ref>
			<ref id="r14">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Faust</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Montenarh</surname>
							<given-names>M</given-names>
						</name>
						</person-group>
						<year>2000</year>
						<article-title>Subcellular localization of protein kinase CK2. A key to its function</article-title>
						<source>Cell Tissue Res</source>	
						<volume>301</volume>
						<fpage>329</fpage>
						<lpage>340</lpage>					
			</citation>
			</ref>
			<ref id="r15">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Flotow</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Graves</surname>
							<given-names>PR</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Fiol</surname>
							<given-names>CJ</given-names>
						</name>
						<name>
							<surname>Roeske</surname>
							<given-names>RW</given-names>
						</name><etal/>
						</person-group>
						<year>1990</year>
						<article-title>Phosphate groups as substrate determinants for casein kinase I action</article-title>
						<source>J Biol Chem</source>
						<volume>265</volume>
						<fpage>14264</fpage>
						<lpage>14269</lpage>
			</citation>
			</ref>
			<ref id="r16">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Frame</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Cohen</surname>
							<given-names>P</given-names>
						</name>
						</person-group>
						<year>2001</year>
						<article-title>GSK3 takes centre stage more than 20 years after its discovery</article-title>
						<source>Biochem J</source>
						<volume>359</volume>
						<fpage>1</fpage>
						<lpage>16</lpage>
			</citation>
			</ref>	
			<ref id="r17">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Hendlich</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Rippmann</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Barnickel</surname>
							<given-names>G</given-names>
						</name>
						</person-group>
						<year>1997</year>
						<article-title>LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins</article-title>
						<source>J Mol Graph Model</source>
						<volume>15</volume>
						<fpage>359</fpage>
						<lpage>363</lpage>
			</citation>
			</ref>
			<ref id="r18">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Hirokawa</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Boon</surname>
							<given-names>CS</given-names>
						</name>
						<name>
							<surname>Mitaku</surname>
							<given-names>S</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>SOSUI: classification and secondary structure prediction system for membrane proteins</article-title>
						<source>Bioinformatics</source>
						<volume>14</volume>
						<fpage>378</fpage>
						<lpage>379</lpage>
			</citation>
			</ref>	
			<ref id="r19">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Hofmann</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Stoffel</surname>
							<given-names>W</given-names>
						</name>
						</person-group>
						<year>1993</year>
						<article-title>TMbase - A database of membrane spanning proteins segments</article-title>
						<source>Biol Chem</source>
						<volume>374</volume>
						<fpage>166</fpage>
						<lpage>170</lpage>
			</citation>
			</ref>
			<ref id="r20">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Hong</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Ma</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Beverley</surname>
							<given-names>SM</given-names>
						</name>
						<name>
							<surname>Turco</surname>
							<given-names>SJ</given-names>
						</name>						
						</person-group>
						<year>2000</year>
						<article-title>The Leishmania GDP-mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits</article-title>
						<source>Biochemistry</source>
						<volume>39</volume>
						<fpage>2013</fpage>
						<lpage>2022</lpage>
			</citation>
			</ref>
			<ref id="r21">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Krogh</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Larsson</surname>
							<given-names>B</given-names>
						</name>	
						<name>
							<surname>Von</surname>
							<given-names>HG</given-names>
						</name>
						<name>
							<surname>Sonnhammer</surname>
							<given-names>EL</given-names>
						</name>		
						</person-group>
						<year>2001</year>
						<article-title>Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes</article-title>
						<source>J Mol Biol</source>
						<volume>305</volume>
						<fpage>567</fpage>
						<lpage>580</lpage>
			</citation>
			</ref>
			<ref id="r22">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Kutay</surname>
							<given-names>U</given-names>
						</name>
						<name>
							<surname>G&uuml;ttinger</surname>
							<given-names>S</given-names>
						</name>	
						</person-group>
						<year>2005</year>
						<article-title>Leucine-rich nuclear-export signals: born to be weak, Trends in Cell Biology</article-title>
						<volume>15</volume>
						<fpage>121</fpage>
						<lpage>124</lpage>
			</citation>
			</ref>	
			<ref id="r23">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Kyte</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Doolittle</surname>
							<given-names>RF</given-names>
						</name>			
						</person-group>
						<year>1982</year>
						<article-title>A simple method for displaying the hydropathic character of a protein</article-title>
						<source>J Mol Biol</source>
						<volume>157</volume>
						<fpage>105</fpage>
						<lpage>132</lpage>
			</citation>
			</ref>	
			<ref id="r24">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Larkin</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Blackshields</surname>
							<given-names>G</given-names>
						</name>	
						<name>
							<surname>Brown</surname>
							<given-names>NP</given-names>
						</name>
						<name>
							<surname>Chenna</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>McGettigan</surname>
							<given-names>PA</given-names>
						</name>	<etal/>				
						</person-group>
						<year>2007</year>
						<article-title>Clustal W and Clustal X version 2.0</article-title>
						<source>Bioinformatics</source>
						<volume>123</volume>
						<fpage>2947</fpage>
						<lpage>2948</lpage>
			</citation>
			</ref>	
			<ref id="r25">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Lu</surname>
							<given-names>KP</given-names>
						</name>
						<name>
							<surname>Liou</surname>
							<given-names>YC</given-names>
						</name>	
						<name>
							<surname>Zhou</surname>
							<given-names>XZ</given-names>
						</name>			
						</person-group>
						<year>2002</year>
						<article-title>Pinning down prolinedirected phosphor-rylation signaling</article-title>
						<source>Trends Cell Biol</source>
						<volume>12</volume>
						<fpage>164</fpage>
						<lpage>172</lpage>
			</citation>
			</ref>	
			<ref id="r26">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ma</surname>
							<given-names>DQ</given-names>
						</name>
						<name>
							<surname>Russell</surname>
							<given-names>DG</given-names>
						</name>	
						<name>
							<surname>Beverley</surname>
							<given-names>SM</given-names>
						</name>
						<name>
							<surname>Turco</surname>
							<given-names>SJ</given-names>
						</name>			
						</person-group>
						<year>2004</year>
						<article-title>Reconstitution of GDP-Man Transport Activity with Purified</article-title>
						<source>J Biol Chem</source>
						<volume>280</volume>
						<fpage>2018</fpage>
						<lpage>2035</lpage>
			</citation>
			</ref>	
			<ref id="r27">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Marshall</surname>
							<given-names>CJ</given-names>
						</name>		
						</person-group>
						<year>1995</year>
						<article-title>Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular
signal-regulated kinase activation</article-title> 
						<source>Cell</source>
						<volume>80</volume>
						<fpage>179</fpage>
						<lpage>185</lpage>
			</citation>
			</ref>		
			<ref id="r28">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Meggio</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Donella</surname>
							<given-names>DA</given-names>
						</name>	
						<name>
							<surname>Pinna</surname>
							<given-names>LA</given-names>
						</name>				
						</person-group>
						<year>1979</year>
						<article-title>Studies on the structural requirements of a microsomal cAMP-independent protein kinase</article-title> 
						<source>FEBS Lett</source>
						<volume>106</volume>
						<fpage>76</fpage>
						<lpage>80</lpage>
			</citation>
			</ref>	
			<ref id="r29">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Muller</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Hoege</surname>
							<given-names>C</given-names>
						</name>	
						<name>
							<surname>Pyrowolakis</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Jentsch</surname>
							<given-names>S</given-names>
						</name>			
						</person-group>
						<year>2001</year>
						<article-title>SUMO, ubiquitin&rsquo;s mysterious cousin</article-title> 
						<source>Nat Rev Mol Cell Biol</source>
						<volume>2</volume>
						<fpage>202</fpage>
						<lpage>210</lpage>
			</citation>
			</ref>		
			<ref id="r30">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ng</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Handman</surname>
							<given-names>E</given-names>
						</name>	
						<name>
							<surname>Bacic</surname>
							<given-names>A</given-names>
						</name>			
						</person-group>
						<year>1994</year>
						<article-title>Biosynthesis of lipophosphoglycan from Leishmania major: characterization of (&szlig;1-3)-galactosyltransferase(s)</article-title> 
						<source>Glycobiology</source>
						<volume>4</volume>
						<fpage>845</fpage>
						<lpage>853</lpage>
			</citation>
			</ref>	
			<ref id="r31">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Nishida</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Gotoh</surname>
							<given-names>Y</given-names>
						</name>			
						</person-group>
						<year>1993</year>
						<article-title>The MAP kinase cascade is essential for diverse signal transduction pathways</article-title> 
						<source>Trends Biochem Sci</source>
						<volume>18</volume>
						<fpage>pp128</fpage>
						<lpage>131</lpage>
			</citation>
			</ref>	
			<ref id="r32">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Paris</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Loiseau</surname>
							<given-names>PM</given-names>
						</name>	
						<name>
							<surname>Bories</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Bre&acute;ard</surname>
							<given-names>J</given-names>
						</name>			
						</person-group>
						<year>2004</year>
						<article-title>Miltefosine Induces Apoptosis-Like Death in <italic>Leishmania donovani</italic> Promastigotes</article-title> 
						<source>Antimicrobial Agents and Chemotherapy</source>
						<volume>48</volume>
						<fpage>pp852</fpage>
						<lpage>859</lpage>
			</citation>
			</ref>
			<ref id="r33">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Pinna</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Ruzzene</surname>
							<given-names>M</given-names>
						</name>			
						</person-group>
						<year>1996</year>
						<article-title>How do protein kinases recognize their substrates</article-title> 
						<source>Biochim Biophys Acta</source>
						<volume>1314</volume>
						<fpage>191</fpage>
						<lpage>225</lpage>
			</citation>
			</ref>	
			<ref id="r34">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Puntervoll</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Linding</surname>
							<given-names>R</given-names>
						</name>	
						<name>
							<surname>Gem&uuml;nd</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Chabanis</surname>
							<given-names>DS</given-names>
						</name>
						<name>
							<surname>Mattingsdal</surname>
							<given-names>M</given-names>
						</name>	<etal/>				
						</person-group>
						<year>2003</year>
						<article-title>ELM server: a new resource for investigating short functional sites in modular eukaryotic
proteins</article-title> 
						<source>Nucleic Acids Res</source> 
						<volume>31</volume>
						<fpage>3625</fpage>
						<lpage>3630</lpage>
			</citation>
			</ref>		
			<ref id="r35">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Rena</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Bain</surname>
							<given-names>J</given-names>
						</name>	
						<name>
							<surname>Elliott</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Cohen</surname>
							<given-names>P</given-names>
						</name>			
						</person-group>
						<year>2004</year>
						<article-title>D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a</article-title> 
						<source>EMBO reports</source> 
						<volume>5</volume>
						<fpage>60</fpage>
						<lpage>65</lpage>
			</citation>
			</ref>	
			<ref id="r36">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Roach</surname>
							<given-names>PJ</given-names>
						</name>		
						</person-group>
						<year>1991</year>
						<article-title>Multisite and hierarchal protein phosphorylation</article-title> 
						<source>J Biol Chem</source> 
						<volume>266</volume>
						<fpage>14139</fpage>
						<lpage>14142</lpage>
			</citation>
			</ref>	
			<ref id="r37">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Rost</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Yachdav</surname>
							<given-names>G</given-names>
						</name>	
						<name>
							<surname>Liu</surname>
							<given-names>J</given-names>
						</name>				
						</person-group>
						<year>2004</year>
						<article-title>The PredictProtein Server</article-title> 
						<source>Nucleic Acids Research</source> 
						<volume>32</volume>
						<fpage>W321</fpage>
						<lpage>W326</lpage>
			</citation>
			</ref>	
			<ref id="r38">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Ruppert</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Welch</surname>
							<given-names>W</given-names>
						</name>	
						<name>
							<surname>Jain</surname>
							<given-names>AN</given-names>
						</name>
						</person-group>
						<year>1997</year>
						<article-title>Automatic identification and representation of protein binding sites for molecular docking</article-title> 
						<source>Protein Science</source> 
						<volume>6</volume>
						<fpage>524</fpage>
						<lpage>533</lpage>
			</citation>
			</ref>	
			<ref id="r39">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Sahoo</surname>
							<given-names>GC</given-names>
						</name>
						<name>
							<surname>Dikhit</surname>
							<given-names>MR</given-names>
						</name>	
						<name>
							<surname>Das</surname>
							<given-names>P</given-names>
						</name>
						</person-group>
						<year>2008</year>
						<article-title>Functional assignment to JEV proteins using SVM</article-title> 
						<source>Bioinformation</source> 
						<volume>3</volume>
						<fpage>1</fpage>
						<lpage>7</lpage>
			</citation>
			</ref>
			<ref id="r40">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Saridakis</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Sheng</surname>
							<given-names>Y</given-names>
						</name>	
						<name>
							<surname>Sarkari</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Holowaty</surname>
							<given-names>MN</given-names>
						</name>	
						<name>
							<surname>Shire</surname>
							<given-names>K</given-names>
						</name><etal/>		
						</person-group>
						<year>2005</year>
						<article-title>Structure of the p53 Binding Domain of HAUSP/USP7 Bound to Epstein-Barr Nuclear Antigen
1 Implications for EBV-Mediated Immortalization</article-title> 
						<source>Molecular Cell</source> 
						<volume>18</volume>
						<fpage>25</fpage>
						<lpage>36</lpage>
			</citation>
			</ref>	
			<ref id="r41">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Songyang</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>KP</given-names>
						</name>	
						<name>
							<surname>Kwon</surname>
							<given-names>YT</given-names>
						</name>
						<name>
							<surname>Tsai</surname>
							<given-names>LH</given-names>
						</name>	
						<name>
							<surname>Filhol</surname>
							<given-names>O</given-names>
						</name><etal/>		
						</person-group>
						<year>1996</year>
						<article-title>A structural basis for substrate specificities of protein Ser/Thr kinases: Primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1</article-title> 						<source>Mol Cell Biol</source> 
						<volume>16</volume>
						<fpage>6486</fpage>
						<lpage>6493</lpage>
			</citation>
			</ref>
			<ref id="r42">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Stephens</surname>
							<given-names>DJ</given-names>
						</name>
						<name>
							<surname>Banting</surname>
							<given-names>G</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>Specificity of interaction between adaptor-complex medium chains and the tyrosine-based sorting motifs of TGN38 and lgp120</article-title> 
						<source>Biochem J</source> 
						<volume>335</volume>
						<fpage>567</fpage>
						<lpage>572</lpage>
			</citation>
			</ref>
			<ref id="r43">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Sturgill</surname>
							<given-names>TW</given-names>
						</name>
						<name>
							<surname>Wu</surname>
							<given-names>J</given-names>
						</name>
						</person-group>
						<year>1991</year>
						<article-title>Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6</article-title> 
						<source>Biochim Biophys Acta</source> 
						<volume>1092</volume>
						<fpage>pp350</fpage>
						<lpage>357</lpage>
			</citation>
			</ref>
			<ref id="r44">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Takeda</surname>
							<given-names>DY</given-names>
						</name>
						<name>
							<surname>Wohlschlegel</surname>
							<given-names>JA</given-names>
						</name>	
						<name>
							<surname>Dutta</surname>
							<given-names>A</given-names>
						</name>
						</person-group>
						<year>2001</year>
						<article-title>A Bipartite Substrate Recognition Motif for Cyclin-Dependent Kinases</article-title> 
						<source>J Biol Chem</source> 
						<volume>276</volume>
						<fpage>1993</fpage>
						<lpage>1997</lpage>
			</citation>
			</ref>	
			<ref id="r45">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Thompson</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>Higgins</surname>
							<given-names>DJ</given-names>
						</name>	
						<name>
							<surname>Gibson</surname>
							<given-names>TJ</given-names>
						</name>
						</person-group>
						<year>1994</year>
						<article-title>CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positionspecific gap penalties and weight matrix choice</article-title> 
						<source>Nucleic Acids Res</source> 
						<volume>22</volume>
						<fpage>4673</fpage>
						<lpage>4680</lpage>
			</citation>
			</ref>
			<ref id="r46">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Tusna&Acirc;dy</surname>
							<given-names>GE</given-names>
						</name>
						<name>
							<surname>Simon</surname>
							<given-names>I</given-names>
						</name>		
						</person-group>
						<year>1998</year>
						<article-title>Principles Governing Amino Acid Composition of Integral Membrane Proteins: Application to Topology Prediction</article-title> 
						<source>J Mol Biol</source> 
						<volume>283</volume>
						<fpage>489</fpage>
						<lpage>506</lpage>
			</citation>
			</ref>
			<ref id="r47">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Tzivion</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Luo</surname>
							<given-names>Z</given-names>
						</name>	
						<name>
							<surname>Avruch</surname>
							<given-names>J</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity</article-title> 
						<source>Nature</source> 
						<volume>394</volume>
						<fpage>88</fpage>
						<lpage>92</lpage>
			</citation>
			</ref>	
			<ref id="r48">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Vergnes</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Gourbal</surname>
							<given-names>B</given-names>
						</name>	
						<name>
							<surname>Girard</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Sundar</surname>
							<given-names>S</given-names>
						</name>	
						</person-group>
						<year>2007</year>
						<article-title>Jolyne Drummelsmith, and Marc Ouellette; A Proteomics Screen Implicates HSP83 and a Small Kinetoplastid Calpain-related Protein in Drug Resistance in <italic>Leishmania donovani</italic> Clinical Field Isolates by Modulating Druginduced Programmed Cell Death</article-title> 
						<source>The American Society for Biochemistry</source> 
						<volume>6</volume>
						<fpage>88</fpage>
						<lpage>101</lpage>
			</citation>
			</ref>
			<ref id="r49">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Vijay</surname>
							<given-names>IK</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>Developmental and Hormonal Regulation of Protein N Glycosylation in the Mammary Gland</article-title> 
						<source>Journal of Mammary Gland Biology and Neoplasia</source> 
						<volume>3</volume>
						<fpage>325</fpage>
						<lpage>336</lpage>
			</citation>
			</ref>	
			<ref id="r50">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Waterman</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Stavridi</surname>
							<given-names>ES</given-names>
						</name>	
						<name>
							<surname>Waterman</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Halazonetis</surname>
							<given-names>TD</given-names>
						</name>
						</person-group>
						<year>1998</year>
						<article-title>ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins</article-title> 
						<source>Nat Genet</source> 
						<volume>19</volume>
						<fpage>175</fpage>
						<lpage>178</lpage>
			</citation>
			</ref>
			<ref id="r51">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Winberg</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Rasmussona</surname>
							<given-names>B</given-names>
						</name>	
						<name>
							<surname>Sundqvista</surname>
							<given-names>T</given-names>
						</name>
						</person-group>
						<year>2007</year>
						<article-title>Leishmania donovani: Inhibition of phagosomal maturation is rescued by nitric oxide in macrophages</article-title> 
						<source>Experimental Parasitology</source> 
						<volume>117</volume>
						<fpage>165</fpage>
						<lpage>170</lpage>
			</citation>
			</ref>	
			<ref id="r52">
				<citation citation-type="journal">
						<person-group>
						<name>
							<surname>Zhou</surname>
							<given-names>XZ</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>PJ</given-names>
						</name>	
						<name>
							<surname>Wulf</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>KP</given-names>
						</name>
						</person-group>
						<year>1999</year>
						<article-title>Phosphorylation- dependent prolyl isomerization: A novel signaling regulatory mechanism</article-title> 
						<source>Cell Mol Life Sci</source> 
						<volume>56</volume>
						<fpage>788</fpage>
						<lpage>806</lpage>
			</citation>
			</ref>									
     </ref-list>		
 	</back>
	<floats-wrap>
	<table-wrap position="float" id="t1">
	<label>Table 1.</label>
	      <caption>
		          <title>Multiple alignment scores of LPG2 protein of different Leishmania strains.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
                  <th align="left" rowspan="2">SeqA</th>
                  <th align="left" rowspan="2">Name</th>
				  <th align="left" rowspan="2">Len (aa)</th>
				  <th align="left" rowspan="2">SeqB</th>
                  <th align="left" rowspan="2">Name</th>
				  <th align="left" rowspan="2">Len (aa)</th>
				  <th align="left" rowspan="2">Score</th>           		
               </tr>
		  </thead>
		  <tbody>
		        <tr>
				   <td>1</td>
				   <td>LPG2_Ldonovani_promastigote_Ld</td>
				   <td>341</td>
				   <td>2</td>
				   <td>LPG2_Lmaxicana_MNYC/BZ/62/M379</td>
				   <td>341</td>
				   <td>94</td>
				 </tr>
				 <tr>
				   <td>1</td>
				   <td>LPG2_Ldonovani_promastigote_Ld</td>
				   <td>341</td>
				   <td>3</td>
				   <td>LPG2_Lmajor_Friedlin</td>
				   <td>341</td>
				   <td>94</td>
				 </tr>
				 <tr>
				   <td>1</td>
				   <td>LPG2_Ldonovani_promastigote_Ld</td>
				   <td>341</td>
				   <td>4</td>
				   <td>LPG2_Linfantum</td>
				   <td>341</td>
				   <td>99</td>
				 </tr>
				 <tr>
				   <td>1</td>
				   <td>LPG2_Ldonovani_promastigote_Ld</td>
				   <td>341</td>
				   <td>5</td>
				   <td>Lbraziliensis_MHOM/BR/75/M2904</td>
				   <td>341</td>
				   <td>78</td>
				 </tr>
				 <tr>
				   <td>2</td>
				   <td>LPG2_Lmaxicana_MNYC/BZ/62/M379</td>
				   <td>341</td>
				   <td>3</td>
				   <td>LPG2_Lmajor_Friedlin</td>
				   <td>341</td>
				   <td>89</td>
				 </tr>
				 <tr>
				   <td>2</td>
				   <td>LPG2_Lmaxicana_MNYC/BZ/62/M379</td>
				   <td>341</td>
				   <td>4</td>
				   <td>LPG2_Linfantum</td>
				   <td>341</td>
				   <td>94</td>
				 </tr>
				 <tr>
				   <td>2</td>
				   <td>LPG2_Lmaxicana_MNYC/BZ/62/M379</td>
				   <td>341</td>
				   <td>5</td>
				   <td>Lbraziliensis_MHOM/BR/75/M2904</td>
				   <td>341</td>
				   <td>78</td>
				 </tr>
				 <tr>
				   <td>3</td>
				   <td>LPG2_Lmajor_Friedlin</td>
				   <td>341</td>
				   <td>4</td>
				   <td>LPG2_Linfantum</td>
				   <td>341</td>
				   <td>93</td>
				 </tr>
				 <tr>
				   <td>3</td>
				   <td>LPG2_Lmajor_Friedlin</td>
				   <td>341</td>
				   <td>5</td>
				   <td>Lbraziliensis_MHOM/BR/75/M2904</td>
				   <td>341</td>
				   <td>78</td>
				 </tr>
				 <tr>
				   <td>4</td>
				   <td>LPG2_Linfantum</td>
				   <td>341</td>
				   <td>5</td>
				   <td>Lbraziliensis_MHOM/BR/75/M2904</td>
				   <td>341</td>
				   <td>78</td>
				 </tr>
		  </tbody>
		  </table>
	</table-wrap>	
	<table-wrap position="float" id="t2">
	<label>Table 2.</label>
	      <caption>
		          <title>Promotif search result summary and Profiles-3D scores of modeled structures of LPG2 proteins of different
Leishmania strains.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
                  <th align="left" rowspan="2">Model Features Strain Names</th>
                  <th align="left" rowspan="2">Number and percentage of alpha helices</th>
				  <th align="left" rowspan="2">Number and percentage of 3,10(310) helices</th>
				  <th align="left" rowspan="2">Number of chains</th>
                  <th align="left" rowspan="2">Profile 3-D scores</th>				             		
               </tr>			   		 		       
		  </thead>
		  <tbody>
		        <tr>
				   <td>L. major</td>
				   <td>17 / 68.9% 7(min)-27(max) residues take part in formation of helices</td>
				   <td>2 / 1.8% 3 residues</td>
				   <td>1</td>
				   <td>111.29/2 (Model 5)</td>
				</tr>
				<tr>
				   <td>L. mexicana</td>
				   <td>17/ 73% 5(min)-28(max) residues take part in formation of helices</td>
				   <td>1 / 0.9% 3 residues</td>
				   <td>1</td>
				   <td>101.8/2 (Model 5)</td>
				</tr>
				<tr>
				   <td>L. infantum</td>
				   <td>21/ 70.4% 4(min)- 23(max) residues take part in formation of helices</td>
				   <td>1 / 0.9 % 4 residues</td>
				   <td>1</td>
				   <td>108.48/8 (Model 4)</td>
				</tr>
				<tr>
				   <td>L. braziliensis</td>
				   <td>19/ 69.2% 4(min)- 24(max) residues take part in formation of helices</td>
				   <td>2/ 1.5% 3 residues</td>
				   <td>1</td>
				   <td>91.23/13 (Model 3)</td>
				</tr>
				<tr>
				   <td>L. donovani</td>
				   <td>24 / 68.3 % 5(min)- 16(max) residues take part in formation of helices</td>
				   <td>3 / 2.3% 3-4 residues</td>
				   <td>1</td>
				   <td>101.8/2 (Model 5)</td>
				</tr>
		  </tbody>
	</table>
	</table-wrap>
	<table-wrap position="float" id="t3">
	<label>Table 3.</label>
	      <caption>
		          <title>Referring to Ramachandran Plots of LPG2 protein of five different strains of Leishmania.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
                  <th align="left" rowspan="2">Residues</th>
                  <th align="left" colspan="5">Number of Amino acids involved</th>
				  <th align="left" colspan="5">Percentage of amino acids involved</th>
			  </tr>
			   <tr>			      
				  <th>Lbrzl</th>
				  <th>Lmjr</th>
				  <th>Linf</th>
				  <th>Lmx</th>
				  <th>Ldv</th>			  
			      <th>Lbrz</th>
				  <th>Lmjr</th>
				  <th>Linf</th>
				  <th>Lmx</th>
				  <th>Ldv</th>
				</tr>  			   
		  </thead>
		  <tbody align="center">
		        <tr>
				   <td>Residues in most favoured regions [A, B, L]</td>
				   <td>270</td>
				   <td>272</td>
				   <td>271</td>
				   <td>276</td>
				   <td>263</td>
				   <td>88.2</td>
				   <td>88.6</td>
				   <td>88.6</td>
				   <td>91.1</td>
				   <td>86.8</td>    
				 </tr>
				 <tr>
				   <td>Residues in additional allowed regions[a,b,l,p]</td>
				   <td>28</td>
				   <td>25</td>
				   <td>20</td>
				   <td>19</td>
				   <td>28</td>
				   <td>9.2</td>
				   <td>8.1</td>
				   <td>6.5</td>
				   <td>6.3</td>
				   <td>9.2</td>    
				 </tr>
				 <tr>
				   <td>Residues in generously allowed regions [~a,~b,~l,~p]</td>
				   <td>3</td>
				   <td>7</td>
				   <td>5</td>
				   <td>4</td>
				   <td>6</td>
				   <td>1</td>
				   <td>2.3</td>
				   <td>1.6</td>
				   <td>1.3</td>
				   <td>2</td>    
				 </tr>
				 <tr>
				   <td>Residues in disallowed regions</td>
				   <td>5</td>
				   <td>3</td>
				   <td>10</td>
				   <td>4</td>
				   <td>6</td>
				   <td>1.6</td>
				   <td>1</td>
				   <td>3.3</td>
				   <td>1.3</td>
				   <td>2</td>    
				 </tr>
				 <tr>
				   <td>Number of non-glycine and non-proline residues</td>
				   <td>306</td>
				   <td>307</td>
				   <td>306</td>
				   <td>303</td>
				   <td>303</td>
				   <td></td>
				   <td></td>
				   <td>100% for all strains</td>
				   <td></td>
				   <td></td>    
				 </tr>
				 <tr>
				   <td>Number of end-residues (excl.Gly and Pro)</td>
				   <td>2</td>
				   <td>2</td>
				   <td>2</td>
				   <td>2</td>
				   <td>2</td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>    
				 </tr>
				 <tr>
				   <td>Number of glycine residues(shown as triangles)</td>
				   <td>21</td>
				   <td>22</td>
				   <td>23</td>
				   <td>25</td>
				   <td>25</td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>    
				 </tr>
				  <tr>
				   <td>Number of proline residues</td>
				   <td>12</td>
				   <td>10</td>
				   <td>10</td>
				   <td>11</td>
				   <td>11</td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>    
				 </tr>
				 <tr>
				   <td>Total number of residues</td>
				   <td>341</td>
				   <td>341</td>
				   <td>341</td>
				   <td>341</td>
				   <td>341</td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td></td>    
				 </tr>
		</tbody>
	</table>
	<table-wrap-foot>
  				<fn>
				   <p>[Abbreviations used in the Table:</p>
				   <p>Lbrzl &ndash;&gt; Leishmania braziliensis; Lmjr &ndash;&gt; Leishmania major;</p>
				   <p>Linf &ndash;&gt; Leishmania infantum; Lmx &ndash;&gt; Leishmania mexicana</p>
				   <p>Ldv &ndash;&gt; Leishmania donovani]</p>
				 </fn>
	</table-wrap-foot>
	</table-wrap>
	<table-wrap position="float" id="t4">
	<label>Table 4.</label>
	      <caption>
		          <title>Comparative analysis of functional assignment of LPG2 protein in various Leishmania strains by SVMProt.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
                  <th align="left" rowspan="2">Functions from NCBI</th>
                  <th align="left" rowspan="2">Friedlin_L. major_CAJ08033</th>
				  <th align="left" rowspan="2">L. donovani_Sudanese1S_AAC46914</th>
				  <th align="left" rowspan="2">MNYC/BZ/62/M379_Belize country L. mexicana</th>
				  <th align="left" rowspan="2">MHOM/BR/75/M2904_L. braziliensis</th>
				  <th align="left" rowspan="2">L. infantum</th>
			  </tr>
		  </thead>
		  <tbody>
		        <tr>
				   <td>Nucleotide-sugar transporter</td>
				   <td>TC 2.A.Electrochemical Potential-driven transporters - Porters(uniporters,symporters,antiporters)</td>
				   <td>TC 2.A.Electrochemical Potential-driven transporters - Porters(uniporters,symporters,antiporters)</td>
				   <td>TC 2.A.Electrochemical Potential-driven transporters - Porters(uniporters,symporters,antiporters) (99.2%)</td>
				   <td>TC 2.A. Electrochemical Potential-driven transporters - Porters(uniporters,symporters,antiporters)</td>
				   <td>TC 2.A. Electrochemical Potential-driven transporters - Porters(uniporters,symporters,antiporters)</td>
				</tr>
				<tr>
				   <td></td>
				   <td>Transmembrane</td>
				   <td>Transmembrane</td>
				   <td>Transmembrane</td>
				   <td>Transmembrane</td>
				   <td>Transmembrane</td>
				 </tr>
				 <tr>
				   <td>1.Posttranslational modification 2.protein turnover</td>
				   <td></td>
				   <td></td>
				   <td>Sodium-binding (78.4%)</td>
				   <td>TC 9.B. Incompletely Characterized Transport Systems - Putative uncharacterized transport proteins (73.8%)</td>
				   <td></td>
				 </tr>
				 <tr>
				   <td></td>
				   <td></td>
				   <td>Iron-binding (58.6%)</td>
				   <td>Iron-binding (73.8%)</td>
				   <td></td>
				   <td>Iron-binding</td>
				 </tr>
				 <tr>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td>Metal-binding</td>
				   <td>G Protein Coupled Receptors (58.6%)</td>
				   <td></td>
				 </tr>
				 <tr>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td>TC 2.A.1 Major facilitator family (MFS) (58.6%)</td>
				   <td>TC 2.A.1 Major facilitator family (MFS) (58.6)</td>
				   <td></td>
				 </tr>
				 <tr>
				   <td>chaperones / Intracellular trafficking and secretion</td>
				   <td></td>
				   <td></td>
				   <td>TC 3.A.5 Type II (general) secretory pathway (IISP) family</td>
				   <td></td>
				   <td></td>
				 </tr>
				 <tr>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td>Copper binding (58.6%)</td>
				   <td></td>
				   <td></td>
				 </tr>
				 <tr>
				   <td></td>
				   <td></td>
				   <td></td>
				   <td>Magnesium binding (58.6%)</td>
				   <td></td>
				   <td></td>
				 </tr>  
		  </tbody>
	</table>
	</table-wrap>
	<table-wrap position="float" id="t5">
	<label>Table 5.</label>
	      <caption>
		          <title>It shows comparative analysis of different motifs of LPG2 protein of five Leishmania strains. The motifs were predicted by Predict Protein server.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
			      <th align="left" rowspan="2">Results</th>
				  <th align="left" rowspan="2">L. donovani</th>
				  <th align="left" rowspan="2">L. mexicana</th>
				  <th align="left" rowspan="2">L. major</th>
				  <th align="left" rowspan="2">L. infantum</th>
				  <th align="left" rowspan="2">L. braziliensis</th>
				</tr>
		 </thead>
		 <tbody>
		       <tr>
			      <td>ASN_GLYCOSYLATION (Nglycosylation site) N[^P][ST][^P]</td>
				  <td>Pattern: 2 &ndash;&gt; NHTR 335 &ndash;&gt; NDTS</td>
				  <td>Pattern: 2 &ndash;&gt; NHTR</td>
				  <td>Pattern: 2 &ndash;&gt; NHTR</td>
				  <td>Pattern: 2 &ndash;&gt; NHTR 335 &ndash;&gt; NDTS</td>
				  <td>Pattern: 2 &ndash;&gt; NHTR</td>
			    </tr>
				<tr>
			      <td>PKC_PHOSPHO_SITE (Proteinkinase C)[ST].[RK]</td>
				  <td>Pattern: 91 &ndash;&gt; SMK 337 &ndash;&gt; TSK</td>
				  <td>Pattern: 91 &ndash;&gt; SMK 337 &ndash;&gt; TSK</td>
				  <td>Pattern: 91 &ndash;&gt; SMK</td>
				  <td>Pattern: 91 &ndash;&gt; SMK 337 &ndash;&gt; TSK</td>
				  <td>Pattern: 91 &ndash;&gt; SMK</td>
			    </tr>
				<tr>
			      <td>CK2_PHOSPHO_SITE ( Casein kinase II phosphorylation site)[ST].{2}[DE]</td>
				  <td>Pattern: 6 &ndash;&gt; SVME 308 &ndash;&gt; SDTE 320 &ndash;&gt; TTAE 338 &ndash;&gt; SKSE</td>
				  <td>Pattern: 6 &ndash;&gt; SVME 338 &ndash;&gt; SKSE</td>
				  <td>Pattern: SDLE &ndash;&gt; 308</td>
				  <td>Pattern: 6 &ndash;&gt; SVME 308 &ndash;&gt; SDTE 320 &ndash;&gt; TTAE 328 &ndash;&gt; SKSE</td>
				  <td>Pattern: TDAE &ndash;&gt; 308</td>
			    </tr>
				<tr>
			      <td>MYRISTYL (N-myristoylation site) G[^EDRKHPFYW].{2}[STAGCN][^P]</td>
				  <td>Pattern: 140 &ndash;&gt; GSLLGA 155 &ndash;&gt; GLVWTF 178 &ndash;&gt; GSVSNS 283 &ndash;&gt; GIMIAL</td>
				  <td>Pattern: 140 &ndash;&gt; GSLLGA 155 &ndash;&gt; GLVWTF 178 &ndash;&gt; GSVSNS 283 &ndash;&gt; GILIAL 336 &ndash;&gt; GTSKSE</td>
				  <td>Pattern: 178 &ndash;&gt; GSVSNS</td>
				  <td>Pattern: 140 &ndash;&gt; GSLLGA 155 &ndash;&gt; GLVWTF 283 &ndash;&gt; GIMIAL</td>
				  <td>Pattern: 178 &ndash;&gt; GSVSNS</td>
			    </tr>
				<tr>
			      <td>DISULFIND</td>
				  <td>20-244(length-224aa)</td>
				  <td>20-244(length-224aa)</td>
				  <td>20-244(length-224aa)</td>
				  <td>20-244(length-224aa)</td>
				  <td>20-244(length-224aa)</td>
			    </tr>
				<tr>
			      <td>Predicted secondary structure</td>
				  <td>H &ndash;&gt; 55.72% E &ndash;&gt; 12.02% L &ndash;&gt; 32.26%</td>
				  <td>H &ndash;&gt; 56.01% E &ndash;&gt; 10.85% L &ndash;&gt; 33.14%</td>
				  <td></td>
				  <td></td>
				  <td></td>
			    </tr>
				<tr>
			      <td>Globularity</td>
				  <td>nexp = 91(number of predicted exposed residues) nfit = 140(number of expected exposed residues diff = -49.00(difference nexp-nfit) So , protein not be globular</td>
				  <td>nexp = 87(number of predicted exposed residues) nfit = 140(number of expected exposed residues diff = -53.00(difference nexp-nfit) So , protein not be globular</td>
				  <td></td>
				  <td></td>
				  <td></td>
			    </tr>
			</tbody>
			</table>
		</table-wrap>
		<table-wrap position="float" id="t6">
	<label>Table 6.</label>
	      <caption>
		          <title>Sequence domains identified in LPG2 protein of different Leishmania strains from ELM server.</title>
		  </caption>
	<table frame="hsides" rules="groups">
	     <thead>
		       <tr>
			      <th align="left" rowspan="2">Identified functional/sequence domain</th>
				  <th align="left" colspan="5">Amino acid sequence and number in the protein sequence of different strains of Leishmania</th>
				  <th align="left" rowspan="2">Comments about reported Domain and protein function</th>
				</tr>
				<tr>
				   <th>L. mexicana</th>
				   <th>L. donovani</th>
				   <th>L. major</th>
				   <th>L. infantum</th>
				   <th>L. braziliensis</th>
				</tr>
		 </thead>
		 <tbody>
		       <tr>
			      <td>LIG_APCC_Dbox_1(R.L.)</td>
				  <td>GRLVLA &ndash;&gt; 223-228</td>
				  <td>---------</td>
				  <td>---------</td>
				  <td>---------</td>
				  <td>---------</td>
				  <td>An RXXL motif binds to either to Cdh1 / Cdc20 components of APC/C thereby targeting protein for destruction in a Cell cycle dependent manner. [Nucleus,cytosol]</td>
				</tr>
				<tr>
				   <td>LIG_CYCLIN_1([RK].L.{0,1}[FYLIV MP] )</td>
				   <td>KNLAV &ndash;&gt; 107-111 RFLY &ndash;&gt; 119-122</td>
				   <td>KWLPL &ndash;&gt; 76-80 KNLAV &ndash;&gt; 107-111 RFLY &ndash;&gt; 119-122</td>
				   <td>KWLPL &ndash;&gt; 76-80 KNLAV &ndash;&gt; 107-111 RFLY &ndash;&gt; 119-122</td>
				   <td>KWLPL &ndash;&gt; 76-80 KNLAV &ndash;&gt; 107-111 RFLY &ndash;&gt; 119-122</td>
				   <td>KNLAV &ndash;&gt; 107-111 RFLY &ndash;&gt; 119-122</td>
				   <td>Substrate recognition site,interacting with cyclin, thereby increasing phosphorrylation by cyclin / cdk Complexes. Predicted protein also should have the MOD_CDK site. Also used by cyclin inhibitors [Nucleus,Cytosol]</td>
				</tr>
				<tr>
				   <td>LIG_FHA_1(..(T). [ILV].)</td>
				   <td>NHTRSVM &ndash;&gt; 2-8 LGTMSVA &ndash;&gt; 95-101 AQTPMVY &ndash;&gt; 125-131 VMTFSVF &ndash;&gt; 236-242 PTTMSVV &ndash;&gt; 250-256 TATGYLG &ndash;&gt; 277-283</td>
				   <td>NHTRSVM &ndash;&gt; 2-8 LGTMSVA &ndash;&gt; 95-101 AQTPMVY &ndash;&gt; 125-131 VLTFSVL &ndash;&gt; 226-232 VMTFSVF &ndash;&gt; 236-242 PTTMSVV &ndash;&gt; 250-256 TATGYLG &ndash;&gt; 277-283</td>
				   <td>NHTRAVM &ndash;&gt; 2-8 LATMSVA &ndash;&gt; 95-101 AQTPMVY &ndash;&gt; 125-131 GETTTLG &ndash;&gt; 217-223 VLTFSVL &ndash;&gt; 226-232 VMTFSVF &ndash;&gt; 236-242 PTTMSVV &ndash;&gt; 250-256 TATGYLG &ndash;&gt; 277-283 TTTESIV &ndash;&gt; 320-326</td>
				   <td>NHTRSVM &ndash;&gt; 2-8 LGTMSVA &ndash;&gt; 95-101 AQTPMVY &ndash;&gt; 125-131 VLTFSVL &ndash;&gt; 226-232 VMTFSVF &ndash;&gt; 236-242 PTTMSVV &ndash;&gt; 250-256 TATGYLG &ndash;&gt; 277-283</td>
				   <td>KATRFID &ndash;&gt; 59-65 AQTPSVY &ndash;&gt; 125-131 SETTSLG &ndash;&gt; 217-223 VMTFSVF &ndash;&gt; 236-242 PTTMSVI &ndash;&gt; 250-256 TATGYVG &ndash;&gt; 277-283</td>
				   <td>Phosphothreonine motif binding a subset of FHA domains that have preference for an acidic amino acid at the Pt+3 position [Nucleus]</td>
				</tr>
				<tr>
				   <td>LIG_FHA_2 (..(T). [DE].)</td>
				   <td>---------</td>
				   <td>GKTTAES &ndash;&gt; 318-324</td>
				   <td>GKTTTES &ndash;&gt; 318-324</td>
				   <td>GKTTTES &ndash;&gt; 318-324</td>
				   <td>SATDAEN &ndash;&gt; 306-312</td>
				   <td>Phosphothreonine motif binding a subset of FHA domains that have a preference for an acidic amino acid at the pT+3 positions.[Nucleus,Replicati on fork]</td>
				</tr>
				<tr>   
				   <td>LIG_MAPK_1 [[KR]{0,2}[KR].{0,2}[KR].{2,4}[ILVM].[ILVF]]</td>
				   <td>---------</td>
				   <td>KKWLPLTL &ndash;&gt; 75-82</td>
				   <td>KKWLPLTL &ndash;&gt; 75-82</td>
				   <td>KKWLPLTL &ndash;&gt; 75-82</td>
				   <td>---------</td>
				   <td>Molecules interacting with MAPK (MAPKKs, substrates, phosphatases) carry docking motif that helps to regulate specific interaction in MAPK cascade.The classic motif approximates (R/K)xxxx#x#,where # is a hydrophobic residue [Nucleus,Cytosol]</td>
				</tr>
				<tr>
				   <td>LIG_USP7_1 ([PA][^P][^FYWIL]S[^P])</td>
				   <td>AKASS &ndash;&gt; 304-308</td>
				   <td>AKASS &ndash;&gt; 304-308</td>
				   <td>ATMSV &ndash;&gt; 96-100 AKASS &ndash;&gt; 304-308</td>
				   <td>AKASS &ndash;&gt; 304-308</td>
				   <td>---------</td>
				   <td>The USP7 NTD domain binding motif variant based on the MDM2 and P53 interactions.[Nucleus]</td>
				</tr>
				<tr>
				   <td>LIG_WW_4 (... [ST]P.)</td>
				   <td>KAQTPM &ndash;&gt; 124-129 SITSPT &ndash;&gt; 246-251</td>
				   <td>KAQTPM &ndash;&gt; 124-129 SITSPT &ndash;&gt; 246-251</td>
				   <td>KAQTPM &ndash;&gt; 124-129 SITSPT &ndash;&gt; 246-251</td>
				   <td>KAQTPM &ndash;&gt; 124-129 SITSPT &ndash;&gt; 246-251</td>
				   <td>KAQTPS &ndash;&gt; 124-129 KWVTPW &ndash;&gt; 149-154 SITSPT &ndash;&gt; 246-251 MNSSPF &ndash;&gt; 319-324</td>
				   <td>Class IV WW domains interaction motif;phosphorylationdependent interaction [Nucleus,Cytosol]</td>	   
				</tr>
				<tr>
				   <td>MOD_CK1_1 ([PA][^P][^FYWIL]S[^P])</td>
				   <td>SVITYSF &ndash;&gt; 13-19 SFCSVSM &ndash;&gt; 18-24 SMKSLGT &ndash;&gt; 91-97 SLGTMSV &ndash;&gt; 94-100 STVSYTL &ndash;&gt; 165-171 SVMTFSV &ndash;&gt; 235-241 SITSPTT &ndash;&gt; 246-252 SSDTGHQ &ndash;&gt; 307-313 SAESIVL &ndash;&gt; 321-327 SKGTSKS &ndash;&gt; 334-340</td>
				   <td>SFCSVSM &ndash;&gt; 18-24 SMKSLGT &ndash;&gt; 91-97 SLGTMSV &ndash;&gt; 94-100 STVSYTL &ndash;&gt; 165-171 SVMTFSV &ndash;&gt; 235-241 SITSPTT &ndash;&gt; 246-252 SPTTMSV &ndash;&gt; 249-255 SSDTEHQ &ndash;&gt; 307-313 SNDTSKS &ndash;&gt; 334-340</td>
				   <td>SFCSVSM &ndash;&gt; 18-24 SMKSLAT &ndash;&gt; 91-97 SLATMSV &ndash;&gt; 94-100 STVSYTL &ndash;&gt; 165-171 SVMTFSV &ndash;&gt; 235-241 SITSPTT &ndash;&gt; 246-252 SPTTMSV &ndash;&gt; 249-255</td>
				   <td>SFCSVSM &ndash;&gt; 18-24 SMKSLGT &ndash;&gt; 91-97 SLGTMSV &ndash;&gt; 94-100 STVSYTL &ndash;&gt; 165-171 SVMTFSV &ndash;&gt; 235-241 SITSPTT &ndash;&gt; 246-252 SPTTMSV &ndash;&gt; 249-255 SSDTGHQ &ndash;&gt; 307-313 SKGTSKS &ndash;&gt; 334-340</td>
				   <td>SFCSVSM &ndash;&gt; 18-24 SAFSLDV &ndash;&gt; 67-73 SMLSTSM &ndash;&gt; 86-92 SMKSLGS &ndash;&gt; 91-97 SLGSMSV &ndash;&gt; 94-100 SETTSLG &ndash;&gt; 217-223 SVMTFSV &ndash;&gt; 235-241 SITSPTT &ndash;&gt; 246-252 SPTTMSV &ndash;&gt; 249-255</td>
				   <td>CK1 phosphorylation site [nucleus,cytosol]</td>				   
				</tr>
				<tr>
				   <td>MOD_CK2_1 (... [ST]P.)</td>
				   <td>HTRSVME &ndash;&gt; 3-9 KGTSKSE &ndash;&gt; 335-341</td>
				   <td>HTRSVME &ndash;&gt; 3-9 KASSDTE &ndash;&gt; 305-311 AGKTTAE &ndash;&gt; 317-323 NDTSKSE &ndash;&gt; 335-341</td>
				   <td>KASSDTE &ndash;&gt; 305-311 TGKTTTE &ndash;&gt; 317-323</td>
				   <td>HTRSVME &ndash;&gt; 3-9 KASSDTE &ndash;&gt; 305-311 AGKTTAE &ndash;&gt; 317-323 NDTSKSE &ndash;&gt; 335-341</td>
				   <td>KASSDTE &ndash;&gt; 305-311</td>
				   <td>CK2 phosphorylation site [nucleus, cytosol, protein kinase CK2 complex]</td>
				</tr>
				<tr>
				   <td>MOD_GSK3_1 (S. ([ST])...)</td>
				   <td>MLFTSMKS &ndash;&gt; 87-94 IVSTVSYT &ndash;&gt; 163-170 VLGSVSNS &ndash;&gt; 176-183 LAFSVLVS &ndash;&gt; 227-234 VLVSSVMT &ndash;&gt; 231-238 MSITSPTT &ndash;&gt; 245-258 TTMSVVGS &ndash;&gt; 251-258 DEISKGTS &ndash;&gt; 331-338</td>
				   <td>MLFTSMKS &ndash;&gt; 87-94 IVSTVSYT &ndash;&gt; 163-170 VLGSVSNS &ndash;&gt; 176-183 LAFSVLVS &ndash;&gt; 227-234 VLVSSVMT &ndash;&gt; 231-238 MSITSPTT &ndash;&gt; 245-258 TTMSVVGS &ndash;&gt; 251-258 DEISKGTS &ndash;&gt; 331-338 AGKTTAES &ndash;&gt; 317-324 DENSNDTS &ndash;&gt; 331-338</td>
				   <td>MLFTSMKS &ndash;&gt; 87-94 IVSTVSYT &ndash;&gt; 163-170 VLGSVSNS &ndash;&gt; 176-183 LAFSVLVS &ndash;&gt; 227-234 VLVSSVMT &ndash;&gt; 231-238 MSITSPTT &ndash;&gt; 245-258 TTMSVVGS &ndash;&gt; 251-258 MQQTGKTT &ndash;&gt; 314-321 TGKTTTES &ndash;&gt; 317-324 LVRTDENS &ndash;&gt; 327-334 DENSNDTS &ndash;&gt; 331-338</td>
				   <td>MLFTSMKS &ndash;&gt; 87-94 IVSTVSYT &ndash;&gt; 163-170 VLGSVSNS &ndash;&gt; 176-183 LAFSVLVS &ndash;&gt; 227-234 VLVSSVMT &ndash;&gt; 231-238 MSITSPTT &ndash;&gt; 245-258 TTMSVVGS &ndash;&gt; 251-258 DEISKGTS &ndash;&gt; 331-338 AGKTTAES &ndash;&gt; 317-324 DENSNDTS &ndash;&gt; 331-338</td>
				   <td>LFVSMLST &ndash;&gt; 83-90 MLSTSMKS &ndash;&gt; 87-94 QTPSVYVS &ndash;&gt; 126-133 IAATVLYT &ndash;&gt; 163-170 YMKTMLGS &ndash;&gt; 172-179 MLGSVSNS &ndash;&gt; 176-183 TAISETTS &ndash;&gt; 214-221 LVFSVLVS &ndash;&gt; 227-234 VLVSSVMT &ndash;&gt; 231-238 MSITSPTT &ndash;&gt; 245-258 TTMSVIGS &ndash;&gt; 251-258 RQQTKMNS &ndash;&gt; 314-321</td>
				   <td>GSK3 phosphorylation recognition site.[Nucleus,Cytosol]</td>
				</tr>
				<tr>
				   <td>MOD_N-GLC_1(. (N)[^P][ST].)</td>
				   <td>MNHTRS &ndash;&gt; 1-6</td>
				   <td>MNHTRS &ndash;&gt; 1-6 SNDTSK &ndash;&gt; 334-339</td>
				   <td>MNHTRS &ndash;&gt; 1-6 ENSSDN &ndash;&gt; 332-337</td>
				   <td>MNHTRS &ndash;&gt; 1-6 SNDTSK &ndash;&gt; 334-339</td>
				   <td>MNHSHI &ndash;&gt; 1-6 LNITAN &ndash;&gt; 297-302 MNSSPF &ndash;&gt; 319-324</td>
				   <td>Generic motif for N-glycosylation.Shakin-Eshleman et al. showed that Trp, Asp,and Glu are uncommon before the Ser/Thr position.Efficient glycosylation usually occurs when &tilde;60 residues or more separate the glycosylation acceptor site from the Cterminus.[extracellular,endoplasmicreticulum,Golgi apparatus]</td>
				</tr>
				<tr>
				   <td>MOD_ProDKin_1 (... ([ST])P..)</td>
				   <td>KAQTPMV &ndash;&gt; 124-130 SITSPTT &ndash;&gt; 246-252</td>
				   <td>KAQTPMV &ndash;&gt; 124-130 SITSPTT &ndash;&gt; 246-252</td>
				   <td>KAQTPMV &ndash;&gt; 124-130 SITSPTT &ndash;&gt; 246-252</td>
				   <td>KAQTPMV &ndash;&gt; 124-130 SITSPTT &ndash;&gt; 246-252</td>
				   <td>KAQTPSV &ndash;&gt; 124-130 KWVTPWG &ndash;&gt; 149-155 SITSPTT &ndash;&gt; 246-252 MNSSPFA &ndash;&gt; 319-325</td>
				   <td>Proline-Directed Kinase (e.g.MAPK) phosphorylation site in higher ukaryotes.[Nucleus,Cytosol]</td>
				</tr>
				<tr>
				   <td>TRG_ENDOCYTIC_2 (Y.[LMVIF])</td>
				   <td>YPAF &ndash;&gt; 66-69 YFSF &ndash;&gt; 131-134 YGPV &ndash;&gt; 187-190 YNNL &ndash;&gt; 192-195 YLGI &ndash;&gt; 281-284 YTHL &ndash;&gt; 294-297</td>
				   <td>YPAF &ndash;&gt; 66-69 YFSF &ndash;&gt; 131-134 YGPV &ndash;&gt; 187-190 YNNL &ndash;&gt; 192-195 YLGI &ndash;&gt; 281-284 YTHL &ndash;&gt; 294-297</td>
				   <td>YPAF &ndash;&gt; 66-69 YFSF &ndash;&gt; 131-134 YGPV &ndash;&gt; 187-190 YNNL &ndash;&gt; 192-195 YLGI &ndash;&gt; 281-284 YTHL &ndash;&gt; 294-297</td>
				   <td>YPAF &ndash;&gt; 66-69 YFSF &ndash;&gt; 131-134 YGPV &ndash;&gt; 187-190 YNNL &ndash;&gt; 192-195 YLGI &ndash;&gt; 281-284 YTHL &ndash;&gt; 294-297</td>
				   <td>YSAF &ndash;&gt; 66-69 YVSF &ndash;&gt; 131-134 YGPV &ndash;&gt; 187-190 YNNL &ndash;&gt; 192-195 YVGI &ndash;&gt; 281-284 YTHL &ndash;&gt; 294-297</td>
				   <td>Tyrosine-based sorting signal responsible for the interaction with mu subunit of AP (Adaptor Protein) complex.[cytosol,plasmamembrane,clathrin-coated endocytic vesicle]</td>
				</tr>
				<tr>
				   <td>TRG_NES_CRM1_1 :([DEQ].{0,1}[LIM].{2,3}[LIVMF].{2,3}[LMVF].[LMIV].{0,3}[DE]|[DE].{0,1}[LIM].{2,3}[LIVMF].{2,3}[LMVF].[LMIV].{0,3}[DEQ]}</td>
				   <td>DMNFPFGILVLQ &ndash;&gt; 36-47 QTILKNLAVVLIALGD &ndash;&gt; 103-118</td>
				   <td>DMNFPFGILVLQ &ndash;&gt; 36-47 QTILKNLAVVLIALGD &ndash;&gt; 103-118</td>
				   <td>DMNFPFGILVLQ &ndash;&gt; 36-47</td>
				   <td>DMNFPFGILVLQ &ndash;&gt; 36-47 QTILKNLAVVLIALGD &ndash;&gt; 103-118</td>
				   <td>DMNFPFGILLLQ &ndash;&gt; 36-47 QTIIKNLAVVLIALGD &ndash;&gt; 103-118</td>
				   <td>Some proteins re-exported from the nucleus contain a Leucine-rich nuclear export signal (NES) binding to the CRM1 exportin protein. [Nucleus,Cytosol]</td>
				</tr>
				<tr>
				   <td>LIG_14-3-3_3 [RHK][STALV].[ST].[PESRDIF]</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>KTTTES &ndash;&gt; 319-324</td>
				   <td>KAQTPS &ndash;&gt; 124-129</td>
				   <td>---------</td>
				   <td>Consensus derived from natural interactors which do not exactly match the mode1 and mode2 ligands. [Nucleus,Cytosol,Internal side of plasmamembrane]</td>
				</tr>
				<tr>
				   <td>MOD_SUMO [ VILMAFP]K.E]</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>FKSE &ndash;&gt; 338-341</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>Motif recognised for modification by SUMO-1.[Nucleus,PML body]</td>
				</tr>
				<tr>
				   <td>LIG_TRAF2_1 [ PSAT].[QE]E]</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>---------</td>
				   <td>APEE &ndash;&gt; 328-331 PEEE &ndash;&gt; 329-332</td>
				   <td>Major TRAF2-binding consensus motif.Members of the tumor necrosis factor receptor (TNFR) superfamily initiate intracellular signaling by recruiting the Cdomain of the TNFR-associated factors (TRAFs) through their cytoplasmic tails. [Cytosol]</td>
				</tr>
			</tbody>
			</table>
		</table-wrap>
		<table-wrap position="float" id="t7">
	    <label>Table 7.</label>
	      <caption>
		          <title>It shows various possible Ligand Binding Sites (LBSs) and total number of amino acids and their positions that involved in each binding site of L. mexicana, L. donovani, L. braziliensis, L. major and L. infantum.</title>
		  </caption>
	    <table frame="hsides" rules="groups">
	     <thead>
		       <tr>
			      <th align="left" rowspan="3">Ligand Binding Site (LBSs)</th>
				  <th align="left" rowspan="3">Total number of amino acids in L. mexicana</th>
				  <th align="left" rowspan="3">Total number of amino acids in L.donovani</th>
				  <th align="left" rowspan="3">Total number of amino acids in L.braziliensis</th>
				  <th align="left" rowspan="3">Total number of amino acids in L.major</th>
				  <th align="left" rowspan="3">Total number of amino acids in L.infantum</th>
			   </tr>
		 </thead>
		 <tbody>
		       <tr>
			      <td>Site 1</td>
				  <td>38</td>
				  <td>37</td>
				  <td>30</td>
				  <td>35</td>
				  <td>37</td>				  
			   </tr>
			   <tr>
			      <td>Site 2</td>
				  <td>36</td>
				  <td>36</td>
				  <td>17</td>
				  <td>24</td>
				  <td>9</td>				  
			   </tr>
			   <tr>
			      <td>Site 3</td>
				  <td>17</td>
				  <td>17</td>
				  <td>18</td>
				  <td>21</td>
				  <td>16</td>				  
			   </tr>
			   <tr>
			      <td>Site 4</td>
				  <td>12</td>
				  <td>12</td>
				  <td>16</td>
				  <td>13</td>
				  <td>11</td>				  
			   </tr>
			   <tr>
			      <td>Site 5</td>
				  <td>10</td>
				  <td>10</td>
				  <td>14</td>
				  <td>10</td>
				  <td>9</td>				  
			   </tr>
			   <tr>
			      <td>Site 6</td>
				  <td>12</td>
				  <td>11</td>
				  <td>14</td>
				  <td>10</td>
				  <td>7</td>				  
			   </tr>
			   <tr>
			      <td>Site 7</td>
				  <td>10</td>
				  <td>10</td>
				  <td>13</td>
				  <td>10</td>
				  <td>4</td>				  
			   </tr>
			   <tr>
			      <td>Site 8</td>
				  <td>9</td>
				  <td>9</td>
				  <td>10</td>
				  <td>14</td>
				  <td>7</td>				  
			   </tr>
			   <tr>
			      <td>Site 9</td>
				  <td>9</td>
				  <td>9</td>
				  <td>14</td>
				  <td>8</td>
				  <td>8</td>				  
			   </tr>
			   <tr>
			      <td>Site 10</td>
				  <td>10</td>
				  <td>10</td>
				  <td>13</td>
				  <td>7</td>
				  <td>7</td>				  
			   </tr>
		</tbody>
		</table>
	  </table-wrap>		   	     
   </floats-wrap> 
</article>
